| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.69e-07 | 6 | 208 | 4 | GO:0016421 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 3.91e-07 | 7 | 208 | 4 | GO:0016885 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.50e-06 | 35 | 208 | 6 | GO:0015020 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | HEXA B3GALNT1 GLT8D1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 MGAT5B CHSY1 UGT2A3 | 4.77e-06 | 153 | 208 | 10 | GO:0008194 |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.10e-05 | 5 | 208 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 6.00e-05 | 8 | 208 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.95e-05 | 70 | 208 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 1.08e-04 | 2 | 208 | 2 | GO:0003989 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.73e-04 | 11 | 208 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | HEXA B3GALNT1 GLT8D1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 MGAT5B CHSY1 PPAT UGT2A3 | 2.28e-04 | 288 | 208 | 11 | GO:0016757 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.39e-04 | 118 | 208 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1E1 MYH8 ATP7B PSMC1 KIF9 ASCC3 DYNC1I1 DNAH3 KIF23 SMC2 DICER1 DNAH1 DNAH17 SMARCA2 SMARCA4 DDX53 DHX34 | 2.51e-04 | 614 | 208 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonuclease III activity | 3.22e-04 | 3 | 208 | 2 | GO:0004525 | |
| GeneOntologyMolecularFunction | ATP:phosphate antiporter activity | 3.22e-04 | 3 | 208 | 2 | GO:0140987 | |
| GeneOntologyMolecularFunction | double-stranded RNA-specific ribonuclease activity | 3.22e-04 | 3 | 208 | 2 | GO:0032296 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 3.73e-04 | 14 | 208 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | HEXA B3GALNT1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 MGAT5B CHSY1 UGT2A3 | 3.82e-04 | 211 | 208 | 9 | GO:0016758 |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 6.39e-04 | 4 | 208 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.47e-04 | 227 | 208 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.10e-04 | 18 | 208 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 1.06e-03 | 5 | 208 | 2 | GO:0047391 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 1.06e-03 | 5 | 208 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 1.06e-03 | 5 | 208 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.06e-03 | 5 | 208 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH8 ATP7B PSMC1 ITPA EFTUD2 KIF9 RND1 GNA11 GNAQ PGP ASCC3 DNAH3 KIF23 RAB20 SMC2 ARHGAP5 SMARCA4 DDX53 DHX34 | 1.28e-03 | 839 | 208 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH8 ATP7B PSMC1 ITPA EFTUD2 KIF9 RND1 GNA11 GNAQ PGP ASCC3 DNAH3 KIF23 RAB20 SMC2 ARHGAP5 SMARCA4 DDX53 DHX34 | 1.30e-03 | 840 | 208 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH8 ATP7B PSMC1 ITPA EFTUD2 KIF9 RND1 GNA11 GNAQ PGP ASCC3 DNAH3 KIF23 RAB20 SMC2 ARHGAP5 SMARCA4 DDX53 DHX34 | 1.30e-03 | 840 | 208 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.58e-03 | 6 | 208 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 1.58e-03 | 6 | 208 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | biotin binding | 1.58e-03 | 6 | 208 | 2 | GO:0009374 | |
| GeneOntologyMolecularFunction | actin binding | MYH8 ACTN4 CLASP2 ACTN3 FMN1 SYNE2 ANTXR1 SHROOM3 SYNE1 FERMT1 ARPC3 PLEKHG3 HDGF | 1.60e-03 | 479 | 208 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | organophosphate:phosphate antiporter activity | 2.19e-03 | 7 | 208 | 2 | GO:0015315 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 2.19e-03 | 7 | 208 | 2 | GO:0070643 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | CYP3A7 CYP3A4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 HSD17B2 CYP3A43 DHRS11 UGT2A3 | 7.91e-11 | 52 | 204 | 10 | GO:0008210 |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 6.31e-07 | 8 | 204 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.57e-06 | 37 | 204 | 6 | GO:0042178 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.61e-06 | 21 | 204 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.84e-06 | 38 | 204 | 6 | GO:0008209 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.86e-06 | 10 | 204 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 4.32e-06 | 12 | 204 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 5.01e-06 | 26 | 204 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 5.01e-06 | 26 | 204 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | CYP3A7 CYP3A4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 HSD17B2 CYP3A43 DHRS11 ECE1 SDR9C7 UGT2A3 ENPEP | 5.81e-06 | 286 | 204 | 13 | GO:0042445 |
| GeneOntologyBiologicalProcess | regulation of melanocyte differentiation | 3.24e-05 | 7 | 204 | 3 | GO:0045634 | |
| GeneOntologyBiologicalProcess | heart development | TRAF3IP2 ERBB2 ACACB ACADM NCAM1 SCN5A PDS5A GNA11 GNAQ AKAP6 ROCK2 RBM15 SYNE1 LEMD2 ECE1 DICER1 LRP2 SMARCA4 IFT122 PRKDC | 6.61e-05 | 757 | 204 | 20 | GO:0007507 |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 7.66e-05 | 9 | 204 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | regulation of pigment cell differentiation | 7.66e-05 | 9 | 204 | 3 | GO:0050932 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 8.21e-05 | 141 | 204 | 8 | GO:0006805 | |
| GeneOntologyBiologicalProcess | demethylation | 8.45e-05 | 24 | 204 | 4 | GO:0070988 | |
| GeneOntologyBiologicalProcess | malonyl-CoA biosynthetic process | 9.73e-05 | 2 | 204 | 2 | GO:2001295 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | CYP3A7 CYP3A4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 HSD17B2 SULT4A1 CYP3A43 DHRS11 SDR9C7 UGT2A3 LRP2 | 1.00e-04 | 376 | 204 | 13 | GO:0008202 |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | HEXA CYP3A7 ACACA ACACB ACADM ACAT1 CYP3A4 ESRRB ACTN3 PTGS1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 CYP3A43 ANKRD26 UGT2A3 C1QTNF9 PCCB | 1.25e-04 | 731 | 204 | 19 | GO:0032787 |
| GeneOntologyBiologicalProcess | spleen development | 1.61e-04 | 52 | 204 | 5 | GO:0048536 | |
| GeneOntologyBiologicalProcess | melanocyte differentiation | 1.82e-04 | 29 | 204 | 4 | GO:0030318 | |
| GeneOntologyBiologicalProcess | ion channel modulating, G protein-coupled receptor signaling pathway | 1.96e-04 | 12 | 204 | 3 | GO:0099105 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 1.96e-04 | 12 | 204 | 3 | GO:0070989 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway | 2.53e-04 | 13 | 204 | 3 | GO:0007207 | |
| GeneOntologyBiologicalProcess | positive regulation of protein K48-linked ubiquitination | 2.90e-04 | 3 | 204 | 2 | GO:1902524 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 2.40e-06 | 40 | 205 | 6 | GO:0005640 | |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 IL16 ATP7B NCAM1 ACTN4 CLASP2 ACTN3 RND1 FMN1 AHNAK SYNE2 SCN5A TNS3 AKAP6 SHROOM3 KIF23 THEMIS DSG1 FERMT1 GRIA1 PTPRU ARPC3 DSG4 EPCAM CDH8 | 1.13e-05 | 976 | 205 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | nuclear membrane | MINDY3 CUEDC2 SYNE2 UGT2B4 UGT2B7 PLCB1 UGT2B10 GNAQ UGT2B28 AKAP6 RBM15 SYNE1 LEMD2 | 4.34e-05 | 349 | 205 | 13 | GO:0031965 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 ATP7B NCAM1 ACTN4 RND1 FMN1 AHNAK SCN5A AKAP6 SHROOM3 THEMIS DSG1 GRIA1 PTPRU DSG4 EPCAM CDH8 | 7.79e-05 | 591 | 205 | 17 | GO:0005911 |
| Domain | Carboxyl_trans | 1.38e-08 | 4 | 204 | 4 | PF01039 | |
| Domain | COA_CT_CTER | 1.38e-08 | 4 | 204 | 4 | PS50989 | |
| Domain | COA_CT_NTER | 1.38e-08 | 4 | 204 | 4 | PS50980 | |
| Domain | COA_CT_N | 1.38e-08 | 4 | 204 | 4 | IPR011762 | |
| Domain | COA_CT_C | 1.38e-08 | 4 | 204 | 4 | IPR011763 | |
| Domain | Carboxyl_trans | 1.38e-08 | 4 | 204 | 4 | IPR000022 | |
| Domain | UDPGT | 2.61e-06 | 21 | 204 | 5 | PF00201 | |
| Domain | UDPGT | 2.61e-06 | 21 | 204 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 2.61e-06 | 21 | 204 | 5 | IPR002213 | |
| Domain | P-loop_NTPase | MYH8 PSMC1 SULT1C4 NDUFA10 EFTUD2 KIF9 SAMD9L RND1 LRRIQ1 GNA11 GNAQ ASCC3 SULT4A1 DNAH3 KIF23 RAB20 SMC2 NLRP2 DICER1 DNAH1 ARHGAP5 SMARCA2 SMARCA4 DDX53 DHX34 | 6.34e-06 | 848 | 204 | 25 | IPR027417 |
| Domain | Cyt_P450_E_grp-II | 1.26e-05 | 5 | 204 | 3 | IPR002402 | |
| Domain | SPEC | 2.34e-05 | 32 | 204 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.34e-05 | 32 | 204 | 5 | IPR018159 | |
| Domain | Cyt_P450_E_CYP3A | 2.51e-05 | 6 | 204 | 3 | IPR008072 | |
| Domain | FAT | 2.51e-05 | 6 | 204 | 3 | PS51189 | |
| Domain | FATC | 2.51e-05 | 6 | 204 | 3 | PS51190 | |
| Domain | FATC_dom | 2.51e-05 | 6 | 204 | 3 | IPR003152 | |
| Domain | PIK_FAT | 2.51e-05 | 6 | 204 | 3 | IPR014009 | |
| Domain | FATC | 2.51e-05 | 6 | 204 | 3 | SM01343 | |
| Domain | - | PSMC1 SULT1C4 NDUFA10 EFTUD2 SAMD9L RND1 GNA11 GNAQ ASCC3 SULT4A1 DNAH3 RAB20 SMC2 NLRP2 DICER1 DNAH1 ARHGAP5 SMARCA2 SMARCA4 DDX53 DHX34 | 7.11e-05 | 746 | 204 | 21 | 3.40.50.300 |
| Domain | - | 7.15e-05 | 21 | 204 | 4 | 3.90.226.10 | |
| Domain | ClpP/crotonase-like_dom | 7.15e-05 | 21 | 204 | 4 | IPR029045 | |
| Domain | Spectrin | 1.04e-04 | 23 | 204 | 4 | PF00435 | |
| Domain | ACTININ_2 | 1.04e-04 | 23 | 204 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.04e-04 | 23 | 204 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.04e-04 | 23 | 204 | 4 | IPR001589 | |
| Domain | Gln-Leu-Gln_QLQ | 1.19e-04 | 2 | 204 | 2 | IPR014978 | |
| Domain | ACC_central | 1.19e-04 | 2 | 204 | 2 | PF08326 | |
| Domain | SnAC | 1.19e-04 | 2 | 204 | 2 | PF14619 | |
| Domain | QLQ | 1.19e-04 | 2 | 204 | 2 | SM00951 | |
| Domain | QLQ | 1.19e-04 | 2 | 204 | 2 | PS51666 | |
| Domain | SnAC | 1.19e-04 | 2 | 204 | 2 | SM01314 | |
| Domain | AcCoA_COase_cen | 1.19e-04 | 2 | 204 | 2 | IPR013537 | |
| Domain | SnAC | 1.19e-04 | 2 | 204 | 2 | IPR029295 | |
| Domain | QLQ | 1.19e-04 | 2 | 204 | 2 | PF08880 | |
| Domain | Spectrin_repeat | 2.65e-04 | 29 | 204 | 4 | IPR002017 | |
| Domain | Ribonuclease_3 | 3.54e-04 | 3 | 204 | 2 | PF00636 | |
| Domain | RIBOc | 3.54e-04 | 3 | 204 | 2 | SM00535 | |
| Domain | RNase_III_dom | 3.54e-04 | 3 | 204 | 2 | IPR000999 | |
| Domain | RNASE_3_1 | 3.54e-04 | 3 | 204 | 2 | PS00517 | |
| Domain | RNASE_3_2 | 3.54e-04 | 3 | 204 | 2 | PS50142 | |
| Domain | - | 3.54e-04 | 3 | 204 | 2 | 1.10.1520.10 | |
| Domain | 7-in-absentia-prot_TRAF-dom | 3.54e-04 | 3 | 204 | 2 | IPR018121 | |
| Domain | Sina | 3.54e-04 | 3 | 204 | 2 | PF03145 | |
| Domain | - | 6.47e-04 | 16 | 204 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.47e-04 | 16 | 204 | 3 | SM00146 | |
| Domain | HSA | 7.02e-04 | 4 | 204 | 2 | SM00573 | |
| Domain | KASH | 7.02e-04 | 4 | 204 | 2 | IPR012315 | |
| Domain | Desmoglein | 7.02e-04 | 4 | 204 | 2 | IPR009123 | |
| Domain | KASH | 7.02e-04 | 4 | 204 | 2 | PS51049 | |
| Domain | SINA-like | 7.02e-04 | 4 | 204 | 2 | IPR004162 | |
| Domain | HSA | 7.02e-04 | 4 | 204 | 2 | PS51204 | |
| Domain | Znf_SIAH | 7.02e-04 | 4 | 204 | 2 | IPR013010 | |
| Domain | KASH | 7.02e-04 | 4 | 204 | 2 | SM01249 | |
| Domain | KASH | 7.02e-04 | 4 | 204 | 2 | PF10541 | |
| Domain | Gprotein_alpha_Q | 7.02e-04 | 4 | 204 | 2 | IPR000654 | |
| Domain | HSA_dom | 7.02e-04 | 4 | 204 | 2 | IPR014012 | |
| Domain | HSA | 7.02e-04 | 4 | 204 | 2 | PF07529 | |
| Domain | PI3_PI4_kinase | 9.28e-04 | 18 | 204 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 9.28e-04 | 18 | 204 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 9.28e-04 | 18 | 204 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 9.28e-04 | 18 | 204 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 9.28e-04 | 18 | 204 | 3 | PS50290 | |
| Domain | HEAT_REPEAT | 1.01e-03 | 70 | 204 | 5 | PS50077 | |
| Domain | Helicase_C | 1.14e-03 | 107 | 204 | 6 | PF00271 | |
| Domain | HELICc | 1.14e-03 | 107 | 204 | 6 | SM00490 | |
| Domain | Biotin_BS | 1.16e-03 | 5 | 204 | 2 | IPR001882 | |
| Domain | Anaphylatoxin_comp_syst | 1.16e-03 | 5 | 204 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.16e-03 | 5 | 204 | 2 | IPR001840 | |
| Domain | ZF_SIAH | 1.16e-03 | 5 | 204 | 2 | PS51081 | |
| Domain | Biotin_COase_C | 1.16e-03 | 5 | 204 | 2 | IPR005482 | |
| Domain | BC | 1.16e-03 | 5 | 204 | 2 | PS50979 | |
| Domain | Biotin_carb_C | 1.16e-03 | 5 | 204 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 1.16e-03 | 5 | 204 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 1.16e-03 | 5 | 204 | 2 | IPR011764 | |
| Domain | CPSASE_1 | 1.16e-03 | 5 | 204 | 2 | PS00866 | |
| Domain | FATC | 1.16e-03 | 5 | 204 | 2 | PF02260 | |
| Domain | BIOTIN | 1.16e-03 | 5 | 204 | 2 | PS00188 | |
| Domain | Helicase_C | 1.20e-03 | 108 | 204 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 1.26e-03 | 109 | 204 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.26e-03 | 109 | 204 | 6 | PS51192 | |
| Domain | DEXDc | 1.26e-03 | 109 | 204 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.32e-03 | 110 | 204 | 6 | IPR014001 | |
| Domain | BRK | 1.73e-03 | 6 | 204 | 2 | SM00592 | |
| Domain | Na_trans_cytopl | 1.73e-03 | 6 | 204 | 2 | PF11933 | |
| Domain | SPOC_C | 1.73e-03 | 6 | 204 | 2 | IPR012921 | |
| Domain | BRK_domain | 1.73e-03 | 6 | 204 | 2 | IPR006576 | |
| Domain | Rudment_hybrid_motif | 1.73e-03 | 6 | 204 | 2 | IPR011054 | |
| Domain | EFhand_Ca_insen | 1.73e-03 | 6 | 204 | 2 | PF08726 | |
| Domain | Na_trans_cytopl | 1.73e-03 | 6 | 204 | 2 | IPR024583 | |
| Domain | EF-hand_Ca_insen | 1.73e-03 | 6 | 204 | 2 | IPR014837 | |
| Domain | CPSASE_2 | 1.73e-03 | 6 | 204 | 2 | PS00867 | |
| Domain | FAT | 1.73e-03 | 6 | 204 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.73e-03 | 6 | 204 | 2 | IPR003151 | |
| Domain | BRK | 1.73e-03 | 6 | 204 | 2 | PF07533 | |
| Domain | SPOC | 1.73e-03 | 6 | 204 | 2 | PF07744 | |
| Domain | ANATO | 2.40e-03 | 7 | 204 | 2 | SM00104 | |
| Domain | Desmosomal_cadherin | 2.40e-03 | 7 | 204 | 2 | IPR009122 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 2.40e-03 | 7 | 204 | 2 | IPR005479 | |
| Domain | ANAPHYLATOXIN_2 | 2.40e-03 | 7 | 204 | 2 | PS01178 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | CYP3A7 CYP3A4 ITPA UGT2B4 UGT2B7 UGT2B10 UGT2B28 CYP3A43 UGT2A3 | 6.62e-09 | 51 | 165 | 9 | M17726 |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | CYP3A7 CYP3A4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 HSD17B2 CYP3A43 UGT2A3 | 1.33e-08 | 55 | 165 | 9 | M14933 |
| Pathway | REACTOME_PREDNISONE_ADME | 2.01e-07 | 23 | 165 | 6 | MM16639 | |
| Pathway | KEGG_RETINOL_METABOLISM | 7.54e-07 | 64 | 165 | 8 | M9488 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.27e-07 | 45 | 165 | 7 | MM15694 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.51e-06 | 70 | 165 | 8 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.88e-06 | 72 | 165 | 8 | M9257 | |
| Pathway | WP_BIOTIN_METABOLISM_INCLUDING_IMDS | 2.18e-06 | 9 | 165 | 4 | M40064 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 5.60e-06 | 11 | 165 | 4 | M27086 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 5.60e-06 | 11 | 165 | 4 | MM14764 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 5.60e-06 | 11 | 165 | 4 | MM15046 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.34e-06 | 24 | 165 | 5 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 9.09e-06 | 25 | 165 | 5 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 9.09e-06 | 25 | 165 | 5 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 9.09e-06 | 25 | 165 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.11e-05 | 26 | 165 | 5 | M39404 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.15e-05 | 44 | 165 | 6 | M45014 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.63e-05 | 28 | 165 | 5 | M19580 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.23e-05 | 15 | 165 | 4 | MM15037 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 3.07e-05 | 6 | 165 | 3 | M47548 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 3.76e-05 | 33 | 165 | 5 | M4086 | |
| Pathway | REACTOME_DRUG_ADME | 4.14e-05 | 109 | 165 | 8 | M45012 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP3A7 CYP3A4 SULT1C4 PTGS1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 SULT4A1 CYP3A43 UGT2A3 | 5.60e-05 | 220 | 165 | 11 | M10320 |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 7.57e-05 | 20 | 165 | 4 | M18415 | |
| Pathway | REACTOME_DRUG_ADME | 7.75e-05 | 119 | 165 | 8 | MM15692 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 8.45e-05 | 8 | 165 | 3 | MM1547 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 8.45e-05 | 8 | 165 | 3 | MM15032 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 8.45e-05 | 8 | 165 | 3 | M27356 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 8.45e-05 | 8 | 165 | 3 | MM15100 | |
| Pathway | REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM | 8.45e-05 | 8 | 165 | 3 | M27248 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.10e-04 | 41 | 165 | 5 | M7399 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 1.12e-04 | 22 | 165 | 4 | M39795 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.60e-04 | 24 | 165 | 4 | M2243 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.60e-04 | 24 | 165 | 4 | M46445 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 1.78e-04 | 10 | 165 | 3 | M1825 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 2.42e-04 | 11 | 165 | 3 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 2.42e-04 | 11 | 165 | 3 | MM15035 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 2.42e-04 | 11 | 165 | 3 | M47637 | |
| Pathway | BIOCARTA_MYOSIN_PATHWAY | 2.42e-04 | 11 | 165 | 3 | M7014 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.90e-04 | 109 | 165 | 7 | M18788 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | CYP3A7 CYP3A4 SULT1C4 UGT2B4 UGT2B7 UGT2B28 SULT4A1 CYP3A43 UGT2A3 | 3.03e-04 | 183 | 165 | 9 | M39588 |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 3.21e-04 | 12 | 165 | 3 | M47649 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 3.45e-04 | 52 | 165 | 5 | M14171 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 5.21e-04 | 14 | 165 | 3 | M39328 | |
| Pathway | WP_GPR40_PATHWAY | 6.46e-04 | 15 | 165 | 3 | M39526 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 6.46e-04 | 15 | 165 | 3 | M138 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 7.88e-04 | 16 | 165 | 3 | M40060 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.08e-03 | 39 | 165 | 4 | MM15695 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP3A4 PTGS1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 SULT4A1 CYP3A43 UGT2A3 | 1.10e-03 | 219 | 165 | 9 | MM14838 |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 1.19e-03 | 40 | 165 | 4 | M41 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 1.33e-03 | 19 | 165 | 3 | MM1361 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 1.33e-03 | 19 | 165 | 3 | M9152 | |
| Pathway | BIOCARTA_TUBBY_PATHWAY | 1.33e-03 | 5 | 165 | 2 | M22076 | |
| Pathway | BIOCARTA_TUBBY_PATHWAY | 1.33e-03 | 5 | 165 | 2 | MM1585 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 1.57e-03 | 43 | 165 | 4 | M238 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.60e-03 | 107 | 165 | 6 | MM14595 | |
| Pubmed | KRT72 ATP6V1E1 IL16 ACAT1 BCAS3 VPS45 PSMC1 NCAM1 ACTN4 CLASP2 ACTN3 RTN1 SACS NMT2 EIF3L PLEKHA5 C4A C4B GNAQ SLC25A23 DYNC1I1 ROCK2 SYNE1 GRIA1 ARPC3 ARHGAP5 ITSN2 H1-0 SMARCA4 MAST1 PLCH1 EXOC4 | 1.38e-10 | 1431 | 208 | 32 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ACACA ACAT1 PSMC1 ACTN4 MCCC2 TRRAP EFTUD2 UBR5 RBM19 AHNAK EIF3L PDS5A PLEKHA5 PGP ASCC3 FAR1 TNS3 RBM15 KIF23 DSG1 COPG1 FERMT1 PTPN23 SMC2 PLEKHG3 H1-0 SMARCA2 SMARCA4 PRKDC DHX34 EXOC4 | 1.53e-10 | 1353 | 208 | 31 | 29467282 |
| Pubmed | KRT72 SMG1 MYH8 ACACB ACTN4 ACTN3 ZEB2 RND1 SACS AHNAK SYNE2 SCN9A ANTXR1 PIP4K2B BOD1L1 ANAPC7 DYNC1I1 ROCK2 SYNE1 ANKRD26 GRIA1 SMC2 ECE1 MINDY2 NMI ITSN2 H1-0 PCDHGB4 IFT122 PRKDC PLCH1 CFAP46 | 1.67e-10 | 1442 | 208 | 32 | 35575683 | |
| Pubmed | ACACA ACACB MCCC2 NDUFA10 ZEB2 UBR5 AHNAK KDM2B PLEKHA5 ASCC3 FAR1 KMT2D ZFHX4 LRP2 PCCB EXOC4 | 5.66e-09 | 418 | 208 | 16 | 34709266 | |
| Pubmed | DCHS2 VPS45 PSMC1 ACTN4 SYNC NDUFA10 ZEB2 SACS NMT2 MERTK SULT4A1 MGAT5B DYNC1I1 AKAP6 SYNE1 BIRC2 SIAH1 CPNE5 ARHGAP5 DROSHA LRP2 SMARCA4 MAST1 IFT122 PRKDC PCCB EXOC4 | 1.61e-08 | 1285 | 208 | 27 | 35914814 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RNF130 PSMC1 EFTUD2 AHNAK USP48 ANAPC7 ROCK2 RBM15 SHROOM3 COPG1 FERMT1 SMC2 INTS13 SMARCA2 SMARCA4 PRKDC DEPDC7 EXOC4 | 1.68e-08 | 582 | 208 | 18 | 20467437 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | NCAM1 ACTN4 SACS UBR5 AHNAK GNA11 GNAQ DYNC1I1 SYNE1 CHSY1 GRIA1 PHF3 EVI5L | 1.74e-08 | 281 | 208 | 13 | 28706196 |
| Pubmed | ACACA ACAT1 ACTN4 TRRAP UBR5 AHNAK SYNE2 EIF3L PDS5A ASCC3 RBM15 KIF23 COPG1 DICER1 PHF3 SMARCA2 SMARCA4 PRKDC NNT | 1.75e-08 | 653 | 208 | 19 | 22586326 | |
| Pubmed | HEXA ATP6V1E1 GLT8D1 ACACA ACAT1 PSMC1 ACTN4 MCCC2 NDUFA10 TRRAP UBR5 AHNAK SYNE2 EIF3L ANTXR1 PDS5A BOD1L1 TMX3 ROCK2 KIF23 COPG1 PTPN23 PIR ECE1 PRKDC IAH1 RPA2 | 1.96e-08 | 1297 | 208 | 27 | 33545068 | |
| Pubmed | HEXA ACACA PSMC1 TRRAP ITPA UBR5 SYNE2 KDM2B PGP ANAPC7 RBM15 SHROOM3 COPG1 SYNE1 PTPN23 ECE1 FAM3A SMARCA4 ROS1 EXOC4 | 3.34e-08 | 754 | 208 | 20 | 35906200 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACACA ACAT1 PSMC1 ACTN4 CLASP2 MCCC2 NDUFA10 EFTUD2 RBM19 EIF3L PDS5A BOD1L1 FAR1 ANAPC7 RBM15 KIF23 DSG1 COPG1 SYNE1 PPAT SMC2 DICER1 H1-0 SMARCA4 PRKDC RPA2 NNT HDGF | 3.53e-08 | 1425 | 208 | 28 | 30948266 |
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 26074487 | ||
| Pubmed | RASSF2 EFTUD2 RGL1 SAMD9L TRPM3 SACS PDS5A PRMT7 ROCK2 ANKRD26 PTPN23 THOC5 PLEKHG3 DNAH17 PLCH1 EXOC4 | 5.61e-08 | 493 | 208 | 16 | 15368895 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ACAT1 PSMC1 ACTN4 TRRAP EFTUD2 SACS UBR5 AHNAK SYNE2 ASCC3 FAR1 ANAPC7 RBM15 DSG1 SYNE1 SMC2 DICER1 ARPC3 PLEKHG3 H1-0 SMARCA4 PRKDC NNT | 6.22e-08 | 1024 | 208 | 23 | 24711643 |
| Pubmed | 8.54e-08 | 8 | 208 | 4 | 32093886 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ACACA ACAT1 BCAS3 ESRRB RBM19 AHNAK ASCC3 ANAPC7 TNS3 DSG1 COPG1 ANKRD26 DICER1 THOC5 PHF3 SERPINB2 PCCB NNT EXOC4 | 8.83e-08 | 724 | 208 | 19 | 36232890 |
| Pubmed | SMG1 UBR5 GPR158 SYNE2 PLCB1 PLEKHA5 AKAP6 SYNE1 PTPN23 DICER1 PHF3 | 1.29e-07 | 225 | 208 | 11 | 12168954 | |
| Pubmed | ACACA MCCC2 TRRAP AHNAK KDM2B PLEKHA5 BOD1L1 ASCC3 KIF23 PTPN23 SMC2 KMT2D PHF3 SMARCA4 PRKDC EXOC4 | 2.40e-07 | 549 | 208 | 16 | 38280479 | |
| Pubmed | ACACA ACACB VPS45 NCAM1 CLASP2 MCCC2 EFTUD2 UBR5 RBM19 AHNAK PDS5A SHROOM3 KIF23 COPG1 FERMT1 ANKRD26 PRKDC DEPDC7 PCCB | 2.61e-07 | 777 | 208 | 19 | 35844135 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB2 ACACA RASSF2 BCAS3 CLASP2 FSIP2 AHNAK RABGAP1L SYNE2 PLEKHA5 BOD1L1 TNS3 RBM15 SHROOM3 KIF23 ANKRD26 PHF3 PLEKHG3 PLCH1 EXOC4 | 2.80e-07 | 861 | 208 | 20 | 36931259 |
| Pubmed | COX16 VPS45 PSMC1 CLASP2 NDUFA10 TRRAP EFR3A RBM19 NMT2 EIF3L KDM2B PDS5A GNA11 ASCC3 FAR1 ANAPC7 SHROOM3 SYNE1 DICER1 ARPC3 TFAP2C PHF3 DROSHA PLEKHG3 INTS13 ITSN2 SMARCA2 | 3.47e-07 | 1497 | 208 | 27 | 31527615 | |
| Pubmed | 3.51e-07 | 25 | 208 | 5 | 36708875 | ||
| Pubmed | ATP6V1E1 ACACA ACTN4 CLASP2 MCCC2 NDUFA10 EFTUD2 KDM2B GNA11 ASCC3 TNS3 ROCK2 RBM15 KIF23 MED10 SMC2 THOC5 DNAH1 PHF3 H1-0 SMARCA2 PRKDC RPA2 HDGF | 5.26e-07 | 1247 | 208 | 24 | 27684187 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ACACA PSMC1 SYNC PTGS1 SAMD9L TRPM3 AHNAK EIF3L PDS5A BOD1L1 CA12 DNAH3 COPG1 ARHGAP5 DROSHA CCDC87 LRP2 PRKDC | 5.44e-07 | 736 | 208 | 18 | 29676528 |
| Pubmed | HEXA GLT8D1 ATP7B PSMC1 NCAM1 CLASP2 EFTUD2 UBR5 RBM19 AHNAK EIF3L PLEKHA5 ASCC3 LEMD2 CHSY1 ECE1 ARPC3 SMARCA4 IFT122 PRKDC DHX34 NNT EXOC4 | 6.25e-07 | 1168 | 208 | 23 | 19946888 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | PSMC1 EFTUD2 AHNAK PDS5A BOD1L1 USP48 KIF23 COPG1 SMC2 PHF3 SMARCA4 PRKDC | 8.77e-07 | 332 | 208 | 12 | 32786267 |
| Pubmed | ACAT1 TRRAP UBR5 AHNAK EIF3L PDS5A BOD1L1 USP48 ANAPC7 RBM15 KIF23 SMC2 TFAP2C THOC5 PHF3 INTS13 SMARCA2 SMARCA4 PRKDC RPA2 HDGF | 8.95e-07 | 1014 | 208 | 21 | 32416067 | |
| Pubmed | 9.64e-07 | 87 | 208 | 7 | 24169447 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACA ACACB VPS45 PSMC1 ACTN4 MCCC2 UBR5 GNA11 DYNC1I1 SHROOM3 ANKRD26 PTPN23 ECE1 ARPC3 ARHGAP5 ITSN2 LRP2 PCCB EXOC4 | 1.05e-06 | 853 | 208 | 19 | 28718761 |
| Pubmed | ERBB2 IL16 ATP7B TRRAP UBR5 SCN5A PIP4K2B ASCC3 FAR1 TMX3 C1orf50 ANAPC7 BIRC2 DICER1 ZFHX4 DROSHA INTS13 SMARCA2 LRP2 SMARCA4 DHX34 EVI5L | 1.09e-06 | 1116 | 208 | 22 | 31753913 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | ACACA PSMC1 MCCC2 EFTUD2 EIF3L FAR1 ANAPC7 COPG1 SMC2 H1-0 PRKDC PCCB | 1.27e-06 | 344 | 208 | 12 | 36282215 |
| Pubmed | 1.32e-06 | 177 | 208 | 9 | 26206133 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ACACA PSMC1 ACTN4 CLASP2 MCCC2 EFTUD2 UBR5 RBM19 AHNAK SYNE2 EIF3L PDS5A PGP ROCK2 DSG1 COPG1 PTPN23 SIAH1 SMC2 ARPC3 DNAAF10 SMARCA4 PRKDC IAH1 HDGF | 1.42e-06 | 1415 | 208 | 25 | 28515276 |
| Pubmed | ACACA ACACB ACADM ACAT1 BCAS3 VPS45 PSMC1 NCAM1 ACTN4 MCCC2 NDUFA10 RTN1 GPR158 RABGAP1L PLCB1 PIP4K2B DSG1 COPG1 UFC1 GRIA1 H1-0 PCCB | 1.53e-06 | 1139 | 208 | 22 | 36417873 | |
| Pubmed | ACADM PSMC1 MCCC2 NDUFA10 EFTUD2 PDS5A TMX3 ANAPC7 COPG1 SMC2 THOC5 INTS13 SUGP1 NNT EXOC4 | 1.64e-06 | 560 | 208 | 15 | 35241646 | |
| Pubmed | SMG1 ACADM VPS45 PSMC1 EFTUD2 UBR5 AHNAK SYNE2 EIF3L PDS5A ASCC3 FAR1 TMX3 KIF23 COPG1 LEMD2 SMC2 DICER1 ARPC3 PLEKHG3 H1-0 PRKDC RPA2 EVI5L EXOC4 | 1.94e-06 | 1440 | 208 | 25 | 30833792 | |
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 2.09e-06 | 5 | 208 | 3 | 11266076 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 28716689 | ||
| Pubmed | An Acetate-Specific GPCR, FFAR2, Regulates Insulin Secretion. | 2.09e-06 | 5 | 208 | 3 | 26075576 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 12193606 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 19943616 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CLASP2 SAMD9L RBM19 PIP4K2B PLEKHA5 TNS3 RBM15 KIF23 ECE1 ZFHX4 PHF3 PRKDC | 2.09e-06 | 361 | 208 | 12 | 26167880 |
| Pubmed | TRAF3IP2 SMG1 ACADM ANTXR1 PLEKHA5 C4A C4B PLXNB1 SMC2 ECE1 DICER1 DROSHA IFT122 PLCH1 DHX34 EXOC4 | 2.19e-06 | 650 | 208 | 16 | 38777146 | |
| Pubmed | AHNAK BOD1L1 ANAPC7 RBM15 KMT2D H1-0 SUGP1 SMARCA4 ELF2 PRKDC | 3.08e-06 | 251 | 208 | 10 | 31076518 | |
| Pubmed | PSMC1 ACTN4 TRRAP ZEB2 ITPA UBR5 PDS5A ANAPC7 RBM15 MED10 PPAT SMC2 ARPC3 KMT2D SUGP1 SMARCA2 SMARCA4 ELF2 PRKDC RPA2 HDGF | 3.35e-06 | 1103 | 208 | 21 | 34189442 | |
| Pubmed | KRT72 MINDY3 UBR5 ASCC3 TMX3 PRMT7 USP48 C1orf50 SHROOM3 BIRC2 PTPN23 MINDY2 KMT2D FAM3A ITSN2 | 4.12e-06 | 604 | 208 | 15 | 38803224 | |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 21193583 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 16615889 | ||
| Pubmed | 5.17e-06 | 209 | 208 | 9 | 36779422 | ||
| Pubmed | SMG1 ACACB PSMC1 MCCC2 TRRAP ZEB2 SYNE2 EIF3L KDM2B PDS5A FAR1 KIF23 MED10 ARPC3 KMT2D ZFHX4 SUGP1 SMARCA2 LRP2 SMARCA4 ELF2 RPA2 PCCB EXOC4 | 5.52e-06 | 1429 | 208 | 24 | 35140242 | |
| Pubmed | 5.59e-06 | 20 | 208 | 4 | 21689717 | ||
| Pubmed | MYH8 ACADM ACAT1 PSMC1 ACTN4 MCCC2 NDUFA10 FSIP2 BOD1L1 PCCB NNT | 5.62e-06 | 331 | 208 | 11 | 29199018 | |
| Pubmed | PSMC1 CLASP2 NDUFA10 UBR5 AHNAK RABGAP1L PLEKHA5 FAR1 ANAPC7 COPG1 DICER1 DNAAF10 PRKDC DHX34 | 6.18e-06 | 547 | 208 | 14 | 37267103 | |
| Pubmed | ERBB2 PSMC1 EFR3A AHNAK PDS5A PLEKHA5 BOD1L1 ASCC3 ROCK2 ANKRD26 PTPN23 SMC2 PRKDC PLCH1 EXOC4 HDGF | 6.43e-06 | 708 | 208 | 16 | 39231216 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ACACA ACTN4 EFTUD2 AHNAK EIF3L SCN5A C4A C4B RBM15 SHROOM3 DSG1 DROSHA PRKDC | 6.85e-06 | 477 | 208 | 13 | 31300519 |
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 7.25e-06 | 7 | 208 | 3 | 11137287 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ACACA ACADM PSMC1 MCCC2 NDUFA10 ITPA EFTUD2 UBR5 ASCC3 FAR1 TMX3 ANAPC7 RBM15 DSG1 COPG1 PPAT SMC2 ARPC3 NMI SMARCA4 PRKDC RPA2 | 7.35e-06 | 1257 | 208 | 22 | 37317656 |
| Pubmed | ACACA ACADM PSMC1 ACTN4 CLASP2 EFTUD2 EIF3L PDS5A ASCC3 COPG1 PTPN23 SMC2 SMARCA4 PRKDC EXOC4 | 7.91e-06 | 638 | 208 | 15 | 33239621 | |
| Pubmed | HEXA ATP7B CLASP2 RTN1 CUEDC2 EIF3L PIP4K2B PLEKHA5 BOD1L1 TNS3 KIF23 DICER1 PHF3 SUGP1 SMARCA4 PLCH1 | 9.90e-06 | 733 | 208 | 16 | 34672954 | |
| Pubmed | ERBB2 ACACA ACACB PLCB1 PLEKHA5 ROCK2 ANKRD26 ARHGAP5 CSNK1G3 ITSN2 PLCH1 EXOC4 | 9.96e-06 | 421 | 208 | 12 | 36976175 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RNF130 ERBB2 ACACA BCAS3 VPS45 CLASP2 MCCC2 TRRAP GPR158 ANTXR1 BOD1L1 TMX3 SHROOM3 HPS3 DNAH1 SLC35F5 OR51E2 PLEKHG3 TBCK SMARCA2 MAST1 IFT122 EVI5L EXOC4 | 1.09e-05 | 1489 | 208 | 24 | 28611215 |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.13e-05 | 175 | 208 | 8 | 25756610 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | ACACA ACACB ACTN4 ZEB2 EFTUD2 UBR5 ASCC3 KIF23 DSG1 SDR9C7 PRKDC | 1.14e-05 | 357 | 208 | 11 | 37059091 |
| Pubmed | 1.14e-05 | 126 | 208 | 7 | 17897319 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MCCC2 TRRAP EFTUD2 AHNAK KDM2B PDS5A ANAPC7 RBM15 KIF23 MED10 LEMD2 SMC2 TFAP2C THOC5 KMT2D PHF3 INTS13 H1-0 SMARCA4 ELF2 PRKDC RPA2 | 1.15e-05 | 1294 | 208 | 22 | 30804502 |
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 10748067 | ||
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 18632858 | ||
| Pubmed | ERBB2 ACACA ACACB ACAT1 VPS45 ACTN4 CLHC1 AHNAK PLEKHA5 ASCC3 ARPC3 EPCAM PCCB | 1.20e-05 | 503 | 208 | 13 | 36217030 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ATP6V1E1 ACACA ACACB ACAT1 PSMC1 ACTN3 ITPA EFTUD2 FAR1 COPG1 PTPN23 SMC2 H1-0 SUGP1 SMARCA4 | 1.29e-05 | 665 | 208 | 15 | 30457570 |
| Pubmed | ACACA RASSF2 PSMC1 RABGAP1L PRMT7 KIF23 COPG1 UFC1 BIRC2 CSNK1G3 PRKDC RPA2 | 1.44e-05 | 437 | 208 | 12 | 20562859 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ACACA ACACB ACADM ACAT1 PSMC1 MCCC2 NDUFA10 EFTUD2 AHNAK EIF3L PIP4K2B ASCC3 FAR1 RBM15 COPG1 SMC2 H1-0 SMARCA2 SMARCA4 PRKDC RPA2 PCCB | 1.53e-05 | 1318 | 208 | 22 | 30463901 |
| Pubmed | Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator. | 1.72e-05 | 9 | 208 | 3 | 1322796 | |
| Pubmed | 1.86e-05 | 91 | 208 | 6 | 22610502 | ||
| Pubmed | Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia. | 1.96e-05 | 27 | 208 | 4 | 28167773 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | ATP6V1E1 ACACA NDUFA10 UBR5 ANAPC7 COPG1 UFC1 DICER1 SMARCA4 | 1.97e-05 | 247 | 208 | 9 | 32989298 |
| Pubmed | SMG1 ERBB2 EFR3A PLCB1 KDM2B PLEKHA5 TMX3 PLXNB1 AKAP6 SHROOM3 CHSY1 DICER1 DHX34 | 2.04e-05 | 529 | 208 | 13 | 14621295 | |
| Pubmed | NCAM1 CLASP2 RTN1 ZEB2 EFTUD2 UBR5 GPR158 SYNE2 PLCB1 PLEKHA5 ROCK2 SHROOM3 KIF23 SYNE1 GRIA1 SMC2 ARPC3 SMARCA4 | 2.20e-05 | 963 | 208 | 18 | 28671696 | |
| Pubmed | 2.27e-05 | 28 | 208 | 4 | 30947518 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HEXA ATP6V1E1 ACACA ACADM PSMC1 ACTN4 EFTUD2 AHNAK EIF3L USP48 TNS3 ROCK2 COPG1 PTPN23 PPAT SMC2 ARPC3 NMI DNAAF10 INTS13 PRKDC RPA2 HDGF | 2.29e-05 | 1455 | 208 | 23 | 22863883 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT72 PSMC1 ACTN4 NDUFA10 EFTUD2 RBM19 AHNAK EIF3L PLEKHA5 ASCC3 RBM15 KIF23 DSG1 SMC2 ARPC3 THOC5 PHF3 PLEKHG3 H1-0 SMARCA4 PRKDC | 2.38e-05 | 1257 | 208 | 21 | 36526897 |
| Pubmed | E3 ligase RFWD3 participates in replication checkpoint control. | 2.45e-05 | 10 | 208 | 3 | 21504906 | |
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 2.45e-05 | 10 | 208 | 3 | 18160036 | |
| Pubmed | 2.45e-05 | 10 | 208 | 3 | 11839798 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ACACA PSMC1 TRRAP UBR5 EIF3L PDS5A ASCC3 COPG1 PTPN23 SMC2 ARPC3 SMARCA2 SMARCA4 PRKDC EXOC4 | 2.49e-05 | 704 | 208 | 15 | 29955894 |
| Pubmed | 2.63e-05 | 29 | 208 | 4 | 21532586 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATP6V1E1 ACACA PSMC1 ACTN4 EFTUD2 RBM19 AHNAK SYNE2 GNA11 TNS3 ROCK2 KIF23 DSG1 COPG1 PTPN23 PIR SMC2 H1-0 SMARCA2 PRKDC NNT HDGF | 2.66e-05 | 1367 | 208 | 22 | 32687490 |
| Pubmed | TRRAP ZEB2 AHNAK PDS5A BOD1L1 ASCC3 CRISPLD1 SMC2 TFAP2C KMT2D H1-0 SMARCA4 | 2.88e-05 | 469 | 208 | 12 | 27634302 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 3.36e-05 | 11 | 208 | 3 | 20427287 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | KRT72 ACAT1 PSMC1 EFTUD2 AHNAK EIF3L FAR1 ROCK2 DSG1 BIRC2 H1-0 CCDC87 PRKDC | 3.54e-05 | 558 | 208 | 13 | 27591049 |
| Pubmed | 3.56e-05 | 102 | 208 | 6 | 21926972 | ||
| Pubmed | 3.56e-05 | 102 | 208 | 6 | 10231032 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 28986474 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 19062096 | ||
| Pubmed | The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan. | 3.56e-05 | 2 | 208 | 2 | 28248732 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 24809345 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 23163725 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 20715157 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 10222050 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.56e-05 | 2 | 208 | 2 | 17645767 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 12207352 | ||
| Interaction | KDM1A interactions | IL16 ACACA ACACB RASSF2 ESRRB PSMC1 MCCC2 NDUFA10 TRRAP ZEB2 EFTUD2 UBR5 AHNAK RABGAP1L KDM2B PDS5A PLEKHA5 ASCC3 FAR1 BIRC2 TFAP2C KMT2D NMI ZFHX4 PLEKHG3 ITSN2 SMARCA2 LRP2 RPA2 PCCB EXOC4 | 8.29e-09 | 941 | 206 | 31 | int:KDM1A |
| Interaction | PHF21A interactions | ACACA ACACB MCCC2 NDUFA10 ZEB2 UBR5 AHNAK RABGAP1L KDM2B PLEKHA5 ASCC3 FAR1 KMT2D ZFHX4 RPA2 PCCB EXOC4 | 9.55e-08 | 343 | 206 | 17 | int:PHF21A |
| Interaction | ISG20 interactions | 1.28e-07 | 13 | 206 | 5 | int:ISG20 | |
| Interaction | RCOR1 interactions | ACACA ACACB ESRRB MCCC2 NDUFA10 ZEB2 UBR5 AHNAK RABGAP1L KDM2B PLEKHA5 ASCC3 FAR1 SMC2 KMT2D ZFHX4 SMARCA4 PCCB EXOC4 HDGF | 1.86e-07 | 494 | 206 | 20 | int:RCOR1 |
| Interaction | NFIX interactions | ACTN4 TRRAP ZEB2 KDM2B PDS5A PIR KMT2D ZFHX4 SMARCA2 ELF2 PCCB NNT | 4.02e-06 | 227 | 206 | 12 | int:NFIX |
| Interaction | HDAC1 interactions | MYH8 ACACA ACACB ACADM BCAS3 ESRRB PSMC1 MCCC2 NDUFA10 ZEB2 EFTUD2 UBR5 AHNAK SYNE2 KDM2B PLEKHA5 ASCC3 FAR1 SMC2 THOC5 KMT2D ZFHX4 SMARCA2 SMARCA4 RPA2 PCCB EXOC4 HDGF | 8.99e-06 | 1108 | 206 | 28 | int:HDAC1 |
| Interaction | SIRT6 interactions | SMG1 ACACA TRRAP EFTUD2 UBR5 PDS5A ASCC3 USP48 ANAPC7 KIF23 SMC2 NLRP2 DICER1 HPS3 PHF3 SMARCA2 SMARCA4 PRKDC RPA2 | 2.58e-05 | 628 | 206 | 19 | int:SIRT6 |
| Interaction | KIF20A interactions | ACADM ACTN4 ACTN3 TRRAP ZEB2 EFR3A EFTUD2 SAMD9L UBR5 RBM19 AHNAK RABGAP1L SYNE2 GNA11 BOD1L1 C4BPA GNAQ MGAT5B SHROOM3 KIF23 SYNE1 PTPN23 ARPC3 SMARCA2 SMARCA4 PRKDC | 2.83e-05 | 1052 | 206 | 26 | int:KIF20A |
| Interaction | SIAH3 interactions | 3.57e-05 | 7 | 206 | 3 | int:SIAH3 | |
| Interaction | CTNNB1 interactions | ERBB2 ACTN4 TRRAP EFTUD2 RND1 UBR5 SYNE2 PLEKHA5 USP48 SHROOM3 KIF23 ANKRD26 SIAH1 PTPRU ARHGAP5 KMT2D SMARCA4 MAST1 PRKDC PLCH1 SLAMF7 RPA2 NNT CDH8 HDGF | 3.92e-05 | 1009 | 206 | 25 | int:CTNNB1 |
| Interaction | HSPB1 interactions | KRT72 RNF130 ACADM ACAT1 PSMC1 ACTN4 MCCC2 TRRAP ITPA EFTUD2 AHNAK ANAPC7 KIF23 ACBD6 THOC5 SMARCA2 SMARCA4 PRKDC RPA2 NNT | 4.14e-05 | 708 | 206 | 20 | int:HSPB1 |
| Interaction | AGAP2 interactions | 6.29e-05 | 210 | 206 | 10 | int:AGAP2 | |
| Interaction | IFITM1 interactions | ATP6V1E1 BCAS3 VPS45 NCAM1 ACTN4 TRRAP FAR1 KIF23 PTPN23 ARPC3 LRP2 RPA2 EXOC4 | 7.83e-05 | 355 | 206 | 13 | int:IFITM1 |
| Interaction | CDC42 interactions | ERBB2 ACACA ACADM VPS45 NCF2 NDUFA10 TRRAP EFR3A AHNAK SYNE2 ANTXR1 PLEKHA5 GNA11 DYNC1I1 ROCK2 DSG1 COPG1 SYNE1 ANKRD26 BIRC2 SMC2 ARPC3 ARHGAP5 PLEKHG3 CSNK1G3 SERPINB2 LRP2 PRKDC RPA2 | 8.33e-05 | 1323 | 206 | 29 | int:CDC42 |
| Interaction | SMC3 interactions | TRRAP EFTUD2 PDS5A MERTK RBM15 COPG1 SMC2 SMARCA2 SMARCA4 ROS1 PRKDC PLCH1 RPA2 HDGF | 8.33e-05 | 408 | 206 | 14 | int:SMC3 |
| Interaction | TOLLIP interactions | MCCC2 UBR5 AHNAK EIF3L ANTXR1 BOD1L1 USP48 KIF23 BIRC2 PTPN23 SIAH1 NMI PRKDC | 8.52e-05 | 358 | 206 | 13 | int:TOLLIP |
| Interaction | KCTD13 interactions | KRT72 ATP6V1E1 IL16 ACAT1 BCAS3 VPS45 PSMC1 NCAM1 ACTN4 CLASP2 ACTN3 RTN1 SACS NMT2 EIF3L PLEKHA5 GNAQ SLC25A23 DYNC1I1 ROCK2 SYNE1 GRIA1 ARPC3 ARHGAP5 ITSN2 H1-0 SMARCA4 MAST1 PLCH1 EXOC4 | 8.63e-05 | 1394 | 206 | 30 | int:KCTD13 |
| Interaction | H1-5 interactions | B3GALNT1 CCDC168 TRRAP EFTUD2 RBM19 PDS5A USP48 KIF23 CYP3A43 SYNE1 ANKRD26 NMI PHF3 DNAH17 H1-0 | 8.84e-05 | 463 | 206 | 15 | int:H1-5 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 8.61e-05 | 157 | 208 | 6 | chr4q13 | |
| Cytoband | 4q13.2 | 3.75e-04 | 31 | 208 | 3 | 4q13.2 | |
| Cytoband | 12q24.11 | 4.52e-04 | 33 | 208 | 3 | 12q24.11 | |
| Cytoband | 16p12.3 | 4.95e-04 | 34 | 208 | 3 | 16p12.3 | |
| Cytoband | 7q21.1 | 5.62e-04 | 8 | 208 | 2 | 7q21.1 | |
| GeneFamily | UDP glucuronosyltransferases | 5.06e-06 | 32 | 144 | 5 | 363 | |
| GeneFamily | Cytochrome P450 family 3 | 2.69e-05 | 8 | 144 | 3 | 1002 | |
| GeneFamily | Dyneins, axonemal | 3.10e-04 | 17 | 144 | 3 | 536 | |
| GeneFamily | Actinins | 3.74e-04 | 4 | 144 | 2 | 1112 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.74e-04 | 4 | 144 | 2 | 1252 | |
| GeneFamily | Desmosomal cadherins | 1.29e-03 | 7 | 144 | 2 | 1188 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.19e-03 | 9 | 144 | 2 | 1234 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.19e-03 | 9 | 144 | 2 | 1203 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 3.15e-03 | 37 | 144 | 3 | 454 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 3.18e-03 | 76 | 144 | 4 | 743 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.31e-03 | 11 | 144 | 2 | 1168 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | TRAF3IP2 ACAT1 CYP3A4 ZEB2 SYNE2 UGT2B4 UGT2B7 UGT2B10 UGT2B28 CYP3A43 UGT2A3 APOL4 ENPEP | 2.35e-06 | 330 | 206 | 13 | MM1120 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CLASP2 TRRAP ZEB2 EFR3A RGL1 SACS UBR5 NMT2 RABGAP1L SYNE2 PDS5A GNAQ ASCC3 ROCK2 KIF23 CHSY1 DICER1 PHF3 ITSN2 SERPINB2 SMARCA2 | 4.37e-06 | 856 | 206 | 21 | M4500 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP | NDUFA10 CD209 EFR3A SAMD9L PXYLP1 MINDY2 RSAD2 ELF2 NNT ENPEP | 4.44e-06 | 200 | 206 | 10 | M7342 |
| Coexpression | BOCHKIS_FOXA2_TARGETS | CYP3A4 BCAS3 SLC25A25 KIF9 UGT2B4 UGT2B7 UGT2B10 C4BPA UGT2B28 MERTK COPG1 CYP3A43 MINDY2 PLEKHG3 PRKDC | 4.81e-06 | 467 | 206 | 15 | MM1233 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | BCAS3 TRPM3 RABGAP1L SYNE2 UGT2B7 PLEKHA5 ANKRD26 LRP2 ENPEP EXOC4 | 1.07e-05 | 221 | 206 | 10 | M39222 |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP | 1.34e-05 | 66 | 206 | 6 | M4342 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | B3GALNT1 RNF130 ATP6V1E1 GLT8D1 ATP7B ACADM ACAT1 PSMC1 MCCC2 PTGS1 ZEB2 ITPA NMT2 C4A GNAQ BIRC2 SIAH2 PPAT SMC2 ARPC3 NMI CSNK1G3 SMARCA2 PRKDC RPA2 PCCB NNT | 1.53e-05 | 1399 | 206 | 27 | M535 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | B3GALNT1 ATP6V1E1 ACADM SACS RABGAP1L SYNE2 USP48 DYNC1I1 KIF23 BIRC2 PIR SMC2 ARHGAP5 NMI PHF3 ITSN2 SMARCA2 | 1.86e-05 | 656 | 206 | 17 | M18979 |
| Coexpression | KAYO_AGING_MUSCLE_UP | 2.34e-05 | 242 | 206 | 10 | M16050 | |
| Coexpression | GSE14000_UNSTIM_VS_4H_LPS_DC_UP | 2.75e-05 | 197 | 206 | 9 | M3345 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON | 2.81e-05 | 75 | 206 | 6 | M5278 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN | 2.98e-05 | 199 | 206 | 9 | M8385 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 3.10e-05 | 200 | 206 | 9 | M6653 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 4.95e-05 | 121 | 206 | 7 | MM935 | |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 6.73e-05 | 221 | 206 | 9 | M15835 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 8.00e-05 | 176 | 206 | 8 | M39223 | |
| Coexpression | BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES | 8.32e-05 | 177 | 206 | 8 | M40028 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CLASP2 TRRAP UBR5 NMT2 PDS5A GNAQ ASCC3 ROCK2 KIF23 CHSY1 PHF3 ITSN2 SMARCA2 | 8.83e-05 | 466 | 206 | 13 | M13522 |
| Coexpression | BILD_SRC_ONCOGENIC_SIGNATURE | 1.01e-04 | 59 | 206 | 5 | M116 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | ACADM COX16 EFR3A ZNF600 SAMD9L SACS RABGAP1L PXYLP1 TMX3 RBM15 THEMIS BIRC2 ARHGAP5 RSAD2 INTS13 SLAMF7 | 1.15e-04 | 687 | 206 | 16 | M41022 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | ACADM UBR5 NMT2 PIP4K2B GNAQ ROCK2 BIRC2 SIAH1 NMI ITSN2 H1-0 SMARCA2 PRKDC | 1.21e-04 | 481 | 206 | 13 | M3898 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | ATP6V1E1 GLT8D1 ACAT1 CLASP2 MCCC2 NDUFA10 TRRAP RTN1 SACS PLCB1 SULT4A1 DYNC1I1 ROCK2 GRIA1 ARPC3 THOC5 CSNK1G3 ITSN2 SMARCA2 EPCAM PCCB NNT CDH8 | 1.36e-04 | 1248 | 206 | 23 | M17728 |
| Coexpression | WINTER_HYPOXIA_METAGENE | 1.38e-04 | 243 | 206 | 9 | M14072 | |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 1.41e-04 | 191 | 206 | 8 | M2647 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.71e-04 | 250 | 206 | 9 | M11318 | |
| Coexpression | GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP | 1.87e-04 | 199 | 206 | 8 | M8347 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN | 1.87e-04 | 199 | 206 | 8 | M6837 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | HEXA GLT8D1 ACADM ACAT1 MCCC2 TRRAP USP48 ANAPC7 COPG1 ECE1 DNAAF10 PRKDC SLAMF7 NNT | 1.90e-04 | 573 | 206 | 14 | M41006 |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 1.93e-04 | 200 | 206 | 8 | M8050 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 1.93e-04 | 200 | 206 | 8 | M8208 | |
| Coexpression | GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN | 1.93e-04 | 200 | 206 | 8 | M3411 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN | 1.93e-04 | 200 | 206 | 8 | M3971 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP | 1.93e-04 | 200 | 206 | 8 | M7475 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP | 1.93e-04 | 200 | 206 | 8 | M9284 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP | 1.93e-04 | 200 | 206 | 8 | M9293 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 2.00e-04 | 201 | 206 | 8 | MM1294 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP | ACADM ACAT1 COX16 PSMC1 NDUFA10 EFR3A RABGAP1L PDS5A FAR1 THEMIS BIRC2 PPAT IAH1 SLAMF7 RPA2 | 2.37e-04 | 658 | 206 | 15 | M40871 |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | RNF130 RASSF2 NCF2 RTN1 ZEB2 CD209 RGL1 FMN1 SCN9A MERTK TNS3 | 2.08e-09 | 194 | 208 | 11 | f09675cd472200363c458952f00d2e41990800ee |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 2.43e-08 | 191 | 208 | 10 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 2.82e-08 | 194 | 208 | 10 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 3.11e-08 | 196 | 208 | 10 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ERBB2 TRPM3 SYNE2 SCNN1G PLXNB1 TNS3 PTPRU ECE1 SMARCA4 EPCAM | 3.76e-08 | 200 | 208 | 10 | ddfb1f006365bf16203ee49f20200f68220cc288 |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 184 | 208 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-07 | 185 | 208 | 9 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.42e-07 | 186 | 208 | 9 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.89e-07 | 190 | 208 | 9 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-07 | 192 | 208 | 9 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 3.16e-07 | 192 | 208 | 9 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-07 | 192 | 208 | 9 | 58a7829b411b02b422ef75e2277a868969cc23e8 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 3.16e-07 | 192 | 208 | 9 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 3.30e-07 | 193 | 208 | 9 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 3.30e-07 | 193 | 208 | 9 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 3.60e-07 | 195 | 208 | 9 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.60e-07 | 195 | 208 | 9 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 3.60e-07 | 195 | 208 | 9 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 4.09e-07 | 198 | 208 | 9 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | (20)_NK_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 4.09e-07 | 198 | 208 | 9 | 178b885e56e734a4408032ea79c68163333de9b6 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.09e-07 | 198 | 208 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 4.09e-07 | 198 | 208 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | (200)_CD56+_NK_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 4.09e-07 | 198 | 208 | 9 | 459e841a01a900808707140297c89c1d6a79024f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.45e-07 | 200 | 208 | 9 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.45e-07 | 200 | 208 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.45e-07 | 200 | 208 | 9 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.45e-07 | 200 | 208 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-07 | 151 | 208 | 8 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 1.35e-06 | 169 | 208 | 8 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 172 | 208 | 8 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 172 | 208 | 8 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-06 | 173 | 208 | 8 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-06 | 177 | 208 | 8 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-06 | 177 | 208 | 8 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.90e-06 | 177 | 208 | 8 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.90e-06 | 177 | 208 | 8 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.90e-06 | 177 | 208 | 8 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 178 | 208 | 8 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 178 | 208 | 8 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 182 | 208 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 185 | 208 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.86e-06 | 187 | 208 | 8 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.98e-06 | 188 | 208 | 8 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.10e-06 | 189 | 208 | 8 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-06 | 190 | 208 | 8 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-06 | 192 | 208 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-06 | 193 | 208 | 8 | 54604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 3.62e-06 | 193 | 208 | 8 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-06 | 194 | 208 | 8 | e3688f4252aae5f849f025d7f453ff4c0c14590b | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.76e-06 | 194 | 208 | 8 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.76e-06 | 194 | 208 | 8 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 194 | 208 | 8 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.90e-06 | 195 | 208 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 3.90e-06 | 195 | 208 | 8 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 3.90e-06 | 195 | 208 | 8 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.90e-06 | 195 | 208 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-06 | 196 | 208 | 8 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 4.05e-06 | 196 | 208 | 8 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.05e-06 | 196 | 208 | 8 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 4.05e-06 | 196 | 208 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.21e-06 | 197 | 208 | 8 | ff34be81ee77efe60618641fa7c1084442b991d7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.21e-06 | 197 | 208 | 8 | 2abe27f6722fa0dab801bca4cd19e34c1fb4173e | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|World / Lineage and Cell class | 4.21e-06 | 197 | 208 | 8 | 604fcbf47f073c2af344e1b16b615a78ef838dc9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.37e-06 | 198 | 208 | 8 | a6b942fe850e287e1cb705684e29218072daf891 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-06 | 198 | 208 | 8 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.37e-06 | 198 | 208 | 8 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-06 | 198 | 208 | 8 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.37e-06 | 198 | 208 | 8 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | (2)_NK/T-(20)_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.37e-06 | 198 | 208 | 8 | 2e4851e49457940e841660c5d781499ffb4a2bf1 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 198 | 208 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.37e-06 | 198 | 208 | 8 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | (2)_NK/T-(200)_CD56+_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 4.37e-06 | 198 | 208 | 8 | 03477a6356a3c08c6e723165c0aac3464ef01667 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.53e-06 | 199 | 208 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 4.53e-06 | 199 | 208 | 8 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-06 | 199 | 208 | 8 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 4.53e-06 | 199 | 208 | 8 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-06 | 199 | 208 | 8 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.70e-06 | 200 | 208 | 8 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.70e-06 | 200 | 208 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Sigmoid-Macrophage|Sigmoid / Region, Cell class and subclass | 4.70e-06 | 200 | 208 | 8 | b07ac0ff3b8530e99094678fed80f35949cafac8 | |
| ToppCell | Sigmoid-(6)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 4.70e-06 | 200 | 208 | 8 | 9e10cca4429de2c4c8c3c6cf2c9e28637a095be9 | |
| ToppCell | COVID-19_Convalescent-CD8+_Tem|COVID-19_Convalescent / Disease condition and Cell class | 4.70e-06 | 200 | 208 | 8 | 1cf2234d5add07e1cd560ca3efa8aafd0851921d | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 4.70e-06 | 200 | 208 | 8 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.70e-06 | 200 | 208 | 8 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Sigmoid-(6)_Macrophage-(60)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 4.70e-06 | 200 | 208 | 8 | ad84a83a5a1893f7b053d39eddeca851463a8ff0 | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.70e-06 | 200 | 208 | 8 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-06 | 200 | 208 | 8 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-06 | 200 | 208 | 8 | 77a68e8fd97a3f3467d25032067fd7ad52ab8522 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.23e-05 | 164 | 208 | 7 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 170 | 208 | 7 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 172 | 208 | 7 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 118 | 208 | 6 | 5f72022f4be3fb7ccec86dc05d37572833028886 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-05 | 118 | 208 | 6 | 053c0986051e36fdc4c48b8067c137b6299b2f1b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-05 | 119 | 208 | 6 | 0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2 | |
| ToppCell | Control-Lymphoid_T/NK-NK_activated|Control / Disease group, lineage and cell class | 2.04e-05 | 119 | 208 | 6 | a258d91ac90d4174b6f203d7f96ba6e57c6003e7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-05 | 119 | 208 | 6 | 28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 178 | 208 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.16e-05 | 179 | 208 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 2.24e-05 | 180 | 208 | 7 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 180 | 208 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 2.51e-08 | 35 | 207 | 7 | CID010436171 | |
| Drug | estrone-d4 | CYP3A7 CYP3A4 ESRRB SULT1C4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 HSD17B2 SULT4A1 CYP3A43 UGT2A3 | 4.73e-08 | 168 | 207 | 12 | CID000000698 |
| Drug | 4-hydroxyestrone | 6.07e-08 | 59 | 207 | 8 | CID000018418 | |
| Drug | 4-nitrophenol | HEXA CYP3A4 SULT1C4 SACS UGT2B4 UGT2B7 UGT2B10 UGT2B28 SULT4A1 UGT2A3 SLAMF7 ENPEP | 8.42e-08 | 177 | 207 | 12 | CID000000980 |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | NCAM1 CD209 RGL1 MINDY3 SCN5A PLEKHA5 GNA11 SLC25A23 SLC35F5 ARHGAP5 DNAH17 H1-0 | 1.72e-07 | 189 | 207 | 12 | 2672_UP |
| Drug | 2-naphthol | CYP3A7 CYP3A4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 SULT4A1 CYP3A43 UGT2A3 | 1.77e-07 | 93 | 207 | 9 | CID000008663 |
| Drug | 2,2,2-trichloroethanol | 3.30e-07 | 73 | 207 | 8 | CID000008259 | |
| Drug | C1 11-32 | 4.61e-07 | 18 | 207 | 5 | CID000443077 | |
| Drug | C11131 | 4.61e-07 | 18 | 207 | 5 | CID000443076 | |
| Drug | T4-G | 6.20e-07 | 19 | 207 | 5 | CID000152424 | |
| Drug | Biotin | 8.07e-07 | 9 | 207 | 4 | DB00121 | |
| Drug | 5 alpha-androstane | 9.83e-07 | 84 | 207 | 8 | CID000094144 | |
| Drug | SN-38 | CYP3A7 IL16 ATP7B CYP3A4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 UGT2A3 H1-0 EPCAM | 1.03e-06 | 184 | 207 | 11 | CID000104842 |
| Drug | 4-hydroxybiphenyl | 1.06e-06 | 59 | 207 | 7 | CID000007103 | |
| Drug | estriol-16-glucuronide | 1.07e-06 | 21 | 207 | 5 | CID000122281 | |
| Drug | alpha-naphthoflavone | CYP3A7 CYP3A4 ESRRB UGT2B4 UGT2B7 UGT2B10 UGT2B28 CYP3A43 UGT2A3 | 1.36e-06 | 118 | 207 | 9 | CID000011790 |
| Drug | estradiol-3-glucuronide | 1.74e-06 | 23 | 207 | 5 | CID000066651 | |
| Drug | p-nitroanisole | 1.97e-06 | 92 | 207 | 8 | CID000007485 | |
| Drug | vicriviroc | 2.42e-06 | 43 | 207 | 6 | CID003009355 | |
| Drug | UDP-N-acetylglucosamine | HEXA B3GALNT1 NCAM1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 SULT4A1 MGAT5B CHSY1 UGT2A3 | 2.70e-06 | 203 | 207 | 11 | CID000001167 |
| Drug | Meldola | 2.81e-06 | 68 | 207 | 7 | CID000081507 | |
| Drug | DB04103 | 2.95e-06 | 97 | 207 | 8 | CID004469987 | |
| Drug | propafenone | 3.18e-06 | 98 | 207 | 8 | CID000004932 | |
| Drug | 4-methylumbelliferone | HEXA CYP3A7 SULT1C4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 SULT4A1 UGT2A3 | 3.45e-06 | 132 | 207 | 9 | CID003364573 |
| Drug | dioxin | HEXA CYP3A7 CYP3A4 ESRRB PTGS1 NMT2 UGT2B4 UGT2B7 UGT2B10 UGT2B28 PGP CYP3A43 UGT2A3 SERPINB2 | 3.86e-06 | 347 | 207 | 14 | CID000015625 |
| Drug | salicylamide | 4.69e-06 | 48 | 207 | 6 | CID000005147 | |
| Drug | L-idaro-1,4-lactone | 4.91e-06 | 28 | 207 | 5 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 5.88e-06 | 29 | 207 | 5 | CID000125641 | |
| Drug | aniline | CYP3A7 CYP3A4 UGT2B4 UGT2B7 UGT2B10 UGT2B28 CYP3A43 SYNE1 UGT2A3 | 6.28e-06 | 142 | 207 | 9 | CID000006115 |
| Drug | oxcarbazepine | 7.01e-06 | 30 | 207 | 5 | CID000034312 | |
| Drug | benzyloxyresorufin | 7.10e-06 | 78 | 207 | 7 | CID000114982 | |
| Drug | hyodeoxycholic acid | 7.31e-06 | 5 | 207 | 3 | ctd:C010471 | |
| Drug | oxazepam | 8.45e-06 | 53 | 207 | 6 | CID000004616 | |
| Drug | Estrone | 8.63e-06 | 112 | 207 | 8 | ctd:D004970 | |
| Drug | 3-methylcholanthrene | CYP3A7 CYP3A4 ESRRB UGT2B4 UGT2B7 UGT2B10 UGT2B28 CYP3A43 ECE1 UGT2A3 ENPEP | 9.26e-06 | 231 | 207 | 11 | CID000001674 |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; HL60; HT_HG-U133A | PTGS1 MINDY3 RBM19 RABGAP1L PIP4K2B PLEKHA5 USP48 DNAH3 SETD4 SUGP1 | 9.52e-06 | 189 | 207 | 10 | 2928_DN |
| Drug | AC1L1AT8 | 1.14e-05 | 33 | 207 | 5 | CID000001138 | |
| Drug | AC1Q6OQG | 1.14e-05 | 33 | 207 | 5 | CID000009686 | |
| Drug | AC1Q7AUJ | 1.19e-05 | 117 | 207 | 8 | CID000003303 | |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A | ATP7B MINDY3 PGP SLC25A23 PLXNB1 DNAH3 FERMT1 SUGP1 DHX34 ENPEP | 1.25e-05 | 195 | 207 | 10 | 7432_DN |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.31e-05 | 196 | 207 | 10 | 2737_DN | |
| Drug | benzphetamine | 1.35e-05 | 119 | 207 | 8 | CID000002341 | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ACTN4 CLASP2 NMT2 PIP4K2B DNAH3 ARHGAP5 PHF3 SMARCA2 DHX34 ENPEP | 1.37e-05 | 197 | 207 | 10 | 3433_DN |
| Drug | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol | 1.45e-05 | 6 | 207 | 3 | ctd:C475721 | |
| Drug | 2-hydroxyestriol | 1.45e-05 | 6 | 207 | 3 | CID000014688 | |
| Drug | pentoxyresorufin | 1.47e-05 | 87 | 207 | 7 | CID000107683 | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | TRAF3IP2 ACACB MINDY3 USP48 DYNC1I1 SETD4 PHF3 SUGP1 IFT122 NNT | 1.49e-05 | 199 | 207 | 10 | 7250_DN |
| Drug | AC1NOWCJ | 1.54e-05 | 35 | 207 | 5 | CID005120112 | |
| Drug | estrone-3-glucuronide | 1.54e-05 | 35 | 207 | 5 | CID000115255 | |
| Drug | SN-38G | 1.58e-05 | 59 | 207 | 6 | CID000443154 | |
| Drug | UDP-alpha-d-xylopyranose | 1.75e-05 | 60 | 207 | 6 | CID000001165 | |
| Drug | moricizine | 1.84e-05 | 18 | 207 | 4 | CID000034632 | |
| Drug | AC1L1K7T | CYP3A7 ERBB2 CYP3A4 BCAS3 ESRRB SULT1C4 PTGS1 UGT2B4 UGT2B7 PLCB1 SULT4A1 KIF23 CYP3A43 TFAP2C DNAAF10 SERPINB2 SMARCA4 PLCH1 | 2.05e-05 | 632 | 207 | 18 | CID000005376 |
| Drug | hexobarbital | 2.17e-05 | 127 | 207 | 8 | CID000003608 | |
| Drug | 3-OHBaP | 2.32e-05 | 63 | 207 | 6 | CID000025890 | |
| Drug | AC1L1FK5 | 2.43e-05 | 129 | 207 | 8 | CID000003272 | |
| Drug | DCNB | 2.61e-05 | 95 | 207 | 7 | CID000007443 | |
| Drug | aminopyrine | CYP3A7 CYP3A4 PTGS1 UGT2B4 UGT2B7 UGT2B10 UGT2B28 CYP3A43 UGT2A3 | 2.79e-05 | 171 | 207 | 9 | CID000006009 |
| Drug | N'-nitrosoanatabine | 2.87e-05 | 20 | 207 | 4 | CID000051291 | |
| Drug | tiglylglycine | 2.87e-05 | 20 | 207 | 4 | CID006441567 | |
| Drug | NSC76436 | 2.87e-05 | 20 | 207 | 4 | CID000002828 | |
| Drug | harmol | 3.01e-05 | 40 | 207 | 5 | CID000068094 | |
| Drug | 1-naphthol | 3.19e-05 | 98 | 207 | 7 | CID000007005 | |
| Drug | testosterone glucuronide | 3.40e-05 | 41 | 207 | 5 | CID000108192 | |
| Drug | 2-AF | 3.40e-05 | 41 | 207 | 5 | CID000005800 | |
| Drug | Biliton | 3.40e-05 | 41 | 207 | 5 | CID000002974 | |
| Drug | methoxyresorufin | 3.91e-05 | 69 | 207 | 6 | CID000119220 | |
| Drug | N'-nitrosoanabasine | 4.27e-05 | 22 | 207 | 4 | CID000014335 | |
| Drug | androsterone glucuronide | 4.30e-05 | 43 | 207 | 5 | CID000114833 | |
| Drug | 3beta-hydroxy-5-spirostene | 4.30e-05 | 43 | 207 | 5 | CID000010536 | |
| Drug | 5 alpha-androstane-3 beta,17 beta-diol | 5.16e-05 | 185 | 207 | 9 | CID000011301 | |
| Drug | 2 E1 | 5.60e-05 | 145 | 207 | 8 | CID006102788 | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | B3GALNT1 MINDY3 PIP4K2B SLC25A23 CA12 SETD4 SIAH2 MINDY2 TFAP2C | 5.61e-05 | 187 | 207 | 9 | 6955_DN |
| Drug | uridine 5'-diphosphoglucuronic acid | UGT2B4 UGT2B7 UGT2B10 UGT2B28 SULT4A1 COPG1 CHSY1 PIR UGT2A3 | 6.09e-05 | 189 | 207 | 9 | CID000000390 |
| Drug | 7-hydroxycoumarin | 6.28e-05 | 75 | 207 | 6 | CID005281426 | |
| Drug | Streptozocin | B3GALNT1 ATP7B ACACA ACADM ACAT1 NCF2 ACTN4 NDUFA10 PTGS1 ZEB2 PLCB1 GNA11 C4B GNAQ HSD17B2 ACBD6 EPCAM NNT ENPEP | 6.55e-05 | 756 | 207 | 19 | ctd:D013311 |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.60e-05 | 191 | 207 | 9 | 4168_DN | |
| Drug | 16-epiestriol | 7.28e-05 | 77 | 207 | 6 | CID000003269 | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | ACACB RBM19 RABGAP1L PIP4K2B SLC25A23 ROCK2 THOC5 DNAH17 ENPEP | 7.44e-05 | 194 | 207 | 9 | 3193_DN |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 6039_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 7.74e-05 | 195 | 207 | 9 | 2283_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 7.74e-05 | 195 | 207 | 9 | 3266_UP | |
| Drug | AC1N8H7N | 7.83e-05 | 78 | 207 | 6 | CID004318740 | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 7330_UP | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 1820_UP | |
| Drug | SC-58125; Down 200; 10uM; SKMEL5; HG-U133A | 8.05e-05 | 196 | 207 | 9 | 507_DN | |
| Drug | Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 7520_DN | |
| Drug | Ranolazine | 8.23e-05 | 2 | 207 | 2 | DB00243 | |
| Drug | YoYo-3 | 8.23e-05 | 2 | 207 | 2 | CID006444584 | |
| Drug | 2,4,6-trichlorobenzimidazole | 8.23e-05 | 2 | 207 | 2 | CID000469437 | |
| Drug | 2,4,5-trichlorobenzimidazole | 8.23e-05 | 2 | 207 | 2 | CID000469438 | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; HL60; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 2912_DN | |
| Drug | Pf-5 | 8.48e-05 | 26 | 207 | 4 | CID000024295 | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | MINDY3 PDS5A USP48 SLC25A23 ROCK2 DHRS11 CSNK1G3 SUGP1 SMARCA4 | 8.70e-05 | 198 | 207 | 9 | 5871_DN |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 7325_UP | |
| Drug | Famotidine [76824-35-6]; Down 200; 11.8uM; PC3; HG-U133A | 8.70e-05 | 198 | 207 | 9 | 1946_DN | |
| Drug | licofelone | 8.99e-05 | 50 | 207 | 5 | CID000133021 | |
| Drug | naphthoquinone | 9.02e-05 | 80 | 207 | 6 | CID000008530 | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 1683_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; HL60; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 2354_UP | |
| Disease | muscular disease (implicated_via_orthology) | 3.18e-06 | 5 | 203 | 3 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ATP6V1E1 ATP7B ACACA RASSF2 ZEB2 SACS PDILT SCNN1G AKAP6 DNAH3 SYNE1 SETD4 PTPRU HPS3 INTS13 LRP2 EXOC4 | 8.12e-06 | 702 | 203 | 17 | C0009402 |
| Disease | Congenital Heart Defects | 1.28e-05 | 44 | 203 | 5 | C0018798 | |
| Disease | X-24947 measurement | 1.44e-05 | 22 | 203 | 4 | EFO_0800910 | |
| Disease | vitamin D measurement | PDILT UGT2B4 UGT2B7 UGT2B10 GNAQ ADAMTS3 DSG1 UGT2A3 SUGP1 SMARCA4 EXOC4 | 2.34e-05 | 336 | 203 | 11 | EFO_0004631 |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.61e-05 | 9 | 203 | 3 | EFO_0600040 | |
| Disease | Phakomatosis cesioflammea | 4.71e-05 | 2 | 203 | 2 | C3838883 | |
| Disease | Congenital hemangioma | 4.71e-05 | 2 | 203 | 2 | C0235753 | |
| Disease | Port-wine stain with oculocutaneous melanosis | 4.71e-05 | 2 | 203 | 2 | C1274879 | |
| Disease | Adenocarcinoma of large intestine | 5.46e-05 | 96 | 203 | 6 | C1319315 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 6.74e-05 | 12 | 203 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 1.29e-04 | 215 | 203 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | Torsades de Pointes | 1.41e-04 | 3 | 203 | 2 | C0040479 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.63e-04 | 117 | 203 | 6 | EFO_0004518, EFO_0005208 | |
| Disease | Malignant neoplasm of breast | ERBB2 ATP7B ACADM CYP3A4 PTGS1 ZEB2 RGL1 SYNE2 PLCB1 BOD1L1 PLXNB1 AKAP6 SYNE1 BIRC2 THOC5 KMT2D ITSN2 SERPINB2 ENPEP | 1.70e-04 | 1074 | 203 | 19 | C0006142 |
| Disease | Disorder of organic acid metabolism | 2.43e-04 | 18 | 203 | 3 | cv:C1263739 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.80e-04 | 4 | 203 | 2 | cv:CN293514 | |
| Disease | glioblastoma (biomarker_via_orthology) | 2.80e-04 | 4 | 203 | 2 | DOID:3068 (biomarker_via_orthology) | |
| Disease | tacrolimus measurement | 2.80e-04 | 4 | 203 | 2 | EFO_0008458 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.80e-04 | 4 | 203 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | estrone conjugate measurement | 2.80e-04 | 4 | 203 | 2 | EFO_0007971 | |
| Disease | metabolonic lactone sulfate measurement | 2.87e-04 | 19 | 203 | 3 | EFO_0800659 | |
| Disease | Intellectual Disability | HEXA TRRAP TRPM3 SACS ASCC3 AKAP6 SYNE1 GRIA1 PTPN23 ACBD6 LRP2 | 2.91e-04 | 447 | 203 | 11 | C3714756 |
| Disease | response to vaccine, cytokine measurement | 3.02e-04 | 131 | 203 | 6 | EFO_0004645, EFO_0004873 | |
| Disease | renal system measurement | 3.35e-04 | 20 | 203 | 3 | EFO_0004742 | |
| Disease | androsterone glucuronide measurement | 3.35e-04 | 20 | 203 | 3 | EFO_0800317 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.65e-04 | 5 | 203 | 2 | C1450051 | |
| Disease | tauro-beta-muricholate measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0800213 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 4.65e-04 | 5 | 203 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Malignant melanoma of iris | 4.65e-04 | 5 | 203 | 2 | C0346373 | |
| Disease | Malignant melanoma of choroid | 4.65e-04 | 5 | 203 | 2 | C0346388 | |
| Disease | glyco-beta-muricholate measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0800569 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.65e-04 | 5 | 203 | 2 | C0410190 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 4.65e-04 | 5 | 203 | 2 | C3281201 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.91e-04 | 200 | 203 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | epiandrosterone sulfate measurement | 6.60e-04 | 25 | 203 | 3 | EFO_0021120 | |
| Disease | Emery-Dreifuss muscular dystrophy | 6.94e-04 | 6 | 203 | 2 | cv:C0410189 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0021119 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 6.94e-04 | 6 | 203 | 2 | C0410189 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0007813, EFO_0010707 | |
| Disease | extraversion measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0007913 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 6.94e-04 | 6 | 203 | 2 | EFO_0800294 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 9.57e-04 | 224 | 203 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | vanillylmandelate (VMA) measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0800119 | |
| Disease | X-24574 measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0800897 | |
| Disease | palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement | 9.67e-04 | 7 | 203 | 2 | EFO_0800400 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.67e-04 | 7 | 203 | 2 | C0751337 | |
| Disease | Liver Cirrhosis, Experimental | GLT8D1 ACAT1 PTGS1 ZEB2 MINDY3 AHNAK RABGAP1L HSD17B2 CHSY1 SMC2 NMI DEPDC7 EPCAM ENPEP | 1.00e-03 | 774 | 203 | 14 | C0023893 |
| Disease | sensory perception of smell | 1.03e-03 | 29 | 203 | 3 | GO_0007608 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.04e-03 | 111 | 203 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | QRS duration | 1.12e-03 | 298 | 203 | 8 | EFO_0005055 | |
| Disease | Diuretic use measurement | 1.15e-03 | 169 | 203 | 6 | EFO_0009928 | |
| Disease | Prostatic Neoplasms | RNF130 ERBB2 IL16 ATP7B CYP3A4 PDS5A CYP3A43 KMT2D ITSN2 LRP2 PRKDC EPCAM | 1.23e-03 | 616 | 203 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | RNF130 ERBB2 IL16 ATP7B CYP3A4 PDS5A CYP3A43 KMT2D ITSN2 LRP2 PRKDC EPCAM | 1.23e-03 | 616 | 203 | 12 | C0376358 |
| Disease | chronic kidney disease | 1.26e-03 | 235 | 203 | 7 | EFO_0003884 | |
| Disease | deoxycholic acid glucuronide measurement | 1.28e-03 | 8 | 203 | 2 | EFO_0800575 | |
| Disease | xerostomia | 1.28e-03 | 8 | 203 | 2 | EFO_0009869 | |
| Disease | Uveal melanoma | 1.28e-03 | 8 | 203 | 2 | C0220633 | |
| Disease | anemia (phenotype), response to ribavirin | 1.64e-03 | 9 | 203 | 2 | EFO_0004272, GO_1901559 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.64e-03 | 9 | 203 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 1.64e-03 | 9 | 203 | 2 | EFO_0800278 | |
| Disease | creatinine measurement, chronic kidney disease | 1.79e-03 | 35 | 203 | 3 | EFO_0003884, EFO_0004518 | |
| Disease | urea measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0011005 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.04e-03 | 10 | 203 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.04e-03 | 10 | 203 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0022090 | |
| Disease | interventricular septum thickness | 2.04e-03 | 10 | 203 | 2 | EFO_0009287 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0800289 | |
| Disease | alpha wave measurement, electroencephalogram measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | vitamin D deficiency | 2.10e-03 | 37 | 203 | 3 | EFO_0003762 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.29e-03 | 80 | 203 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 2.49e-03 | 11 | 203 | 2 | EFO_0801531 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 2.49e-03 | 11 | 203 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 2.49e-03 | 11 | 203 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 2.49e-03 | 11 | 203 | 2 | EFO_0800295 | |
| Disease | Cutaneous Melanoma | 2.82e-03 | 41 | 203 | 3 | C0151779 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.97e-03 | 12 | 203 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | methionine sulfone measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0800072 | |
| Disease | decanoylcarnitine measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0021039 | |
| Disease | Sudden infant death syndrome | 2.97e-03 | 12 | 203 | 2 | C0038644 | |
| Disease | temporal pole volume measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0010334 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0800291 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.00e-03 | 274 | 203 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 3.23e-03 | 43 | 203 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | triglycerides in large LDL measurement | 3.23e-03 | 43 | 203 | 3 | EFO_0022319 | |
| Disease | Coffin-Siris syndrome | 3.49e-03 | 13 | 203 | 2 | C0265338 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 3.49e-03 | 13 | 203 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 3.49e-03 | 13 | 203 | 2 | EFO_0800284 | |
| Disease | microsatellite instability measurement, colorectal cancer, overall survival | 3.49e-03 | 13 | 203 | 2 | EFO_0000638, EFO_0007054, MONDO_0005575 | |
| Disease | X-19141 measurement | 3.49e-03 | 13 | 203 | 2 | EFO_0800799 | |
| Disease | Mammary Carcinoma, Human | ERBB2 ATP7B CYP3A4 PTGS1 ZEB2 SYNE1 BIRC2 KMT2D ITSN2 SERPINB2 | 3.62e-03 | 525 | 203 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | ERBB2 ATP7B CYP3A4 PTGS1 ZEB2 SYNE1 BIRC2 KMT2D ITSN2 SERPINB2 | 3.62e-03 | 525 | 203 | 10 | C1257931 |
| Disease | total lipids in very small VLDL measurement | 3.68e-03 | 45 | 203 | 3 | EFO_0022156 | |
| Disease | Mammary Neoplasms | ERBB2 ATP7B CYP3A4 PTGS1 ZEB2 SYNE1 BIRC2 KMT2D ITSN2 SERPINB2 | 3.71e-03 | 527 | 203 | 10 | C1458155 |
| Disease | non-high density lipoprotein cholesterol measurement | COX16 RABGAP1L SYNE2 PDS5A ASCC3 ADAMTS3 DHRS11 CSNK1G3 ITSN2 SUGP1 SMARCA4 PCCB | 4.05e-03 | 713 | 203 | 12 | EFO_0005689 |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 4.06e-03 | 14 | 203 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | X-21470 measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0800817 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 4.06e-03 | 14 | 203 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0800283 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0004611, EFO_0008589 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPEDVKMALEVYKLS | 561 | P04003 | |
| ATDMPVKNQYSELLK | 131 | Q96CN4 | |
| PKANKEILDEAYVMA | 761 | P04626 | |
| YVDEKAPEFSMQGLK | 251 | P16422 | |
| IKEALIVIDKSYMNP | 416 | Q92754 | |
| EKAKNARVKMPEQEY | 411 | Q9H6X2 | |
| DKPVESMQTKLNYLR | 31 | Q5JRM2 | |
| VRKKEVYMPSSIFQD | 186 | P0C0L5 | |
| IAVASMNYDPIVSKV | 556 | Q96NN9 | |
| MNYDPIVSKVAEVLA | 561 | Q96NN9 | |
| YISIVMDAETQKKFP | 236 | Q8WTX7 | |
| LTPYVAIEDKDMQQK | 86 | Q9BPW4 | |
| VALMAGKAEIKYDPE | 521 | P35670 | |
| PKYSDMIVAAIQAEK | 26 | P07305 | |
| LADMYQPRSLVDKAK | 231 | Q9BQL6 | |
| NAFEVAEKYLDIPKM | 226 | O43707 | |
| EDCIQMYFKVKAPIT | 66 | Q8IYW2 | |
| MVTPEDLKANAEYIK | 156 | Q13085 | |
| NVKGEYDVTMPKVES | 831 | Q09666 | |
| KDVRNPEAEEMKATY | 261 | Q9H467 | |
| AVGELPEKSKMQEIY | 156 | Q9NNX6 | |
| PEKSKMQEIYQELTR | 161 | Q9NNX6 | |
| FSQIRYDAVKSKMDP | 36 | Q9P0S2 | |
| ALMDYKVFEAVPTKV | 101 | Q96QD5 | |
| FNTEYPVEKLMRDAK | 381 | P11310 | |
| SPSQAMQEYIAVVKK | 106 | Q9BR61 | |
| KEYASSGPALQMKEV | 601 | Q9UPS8 | |
| LEVPDKDQVDMTIKY | 691 | Q9NVE4 | |
| PISNYIMLADTDKIK | 556 | Q9UPY3 | |
| EMVKSIQFKTPIYDL | 176 | Q9H6U6 | |
| DMEKLTFYAVSAPEK | 36 | Q14156 | |
| ILKYKMLDEQDVPAA | 161 | Q9NX57 | |
| PAKALAKSEEDYLVM | 936 | Q96T37 | |
| EPKAAVQKELSDMDY | 196 | Q9Y4C8 | |
| EYIKQNPMATEKLLS | 981 | Q29RF7 | |
| DVAQYIKFEMPVLKS | 271 | P50749 | |
| KELVIPDSANVFYAM | 706 | Q9NZL6 | |
| EKQMVVVCKESPKEY | 1281 | Q68DA7 | |
| VIYNNKSKEEPVTMT | 131 | Q86XS8 | |
| NYVEKMPSSENEKAV | 811 | Q9NZM3 | |
| EAEMEKQKVARYFPT | 1291 | Q9H3S7 | |
| KMFVDLNPDSDKIIY | 311 | P50148 | |
| KTIYNLVDMERKNDP | 496 | Q9NVM9 | |
| INKEKSDGSKYPEMV | 181 | Q9UN71 | |
| VVMVTPEDLKANAEY | 296 | O00763 | |
| PEDLKANAEYIKMAD | 301 | O00763 | |
| QCLPSEIEVKYKMAE | 96 | Q9UJX3 | |
| DLVSDPEYINLMKNK | 336 | Q9H8M7 | |
| TKKYVLNEEMSGLPA | 441 | Q8WVX9 | |
| IKEPKAAVEMYISAG | 761 | Q9HBG6 | |
| IPANIRIYDSVKKMV | 231 | O60551 | |
| AYVPAMADENIIVRK | 221 | Q9HCC0 | |
| PYSQVRDMVSKKLEL | 371 | P19878 | |
| KMKINNEEIVSDPIY | 176 | Q12866 | |
| KSKCIPVMEAQEYIA | 296 | Q8NC56 | |
| NIELNKKSMYSRVPE | 296 | Q9Y262 | |
| AQKLAEEVPMDVASY | 71 | Q5T848 | |
| PNAKYVMKTDTDVFI | 171 | O75752 | |
| ELVYNKSKPVAVTGM | 431 | O14576 | |
| LKVVKMLDYEQAPNI | 331 | Q86SJ6 | |
| ADIAQKMVAIPTKYT | 3576 | Q5CZC0 | |
| YPIQRSKKDSEGIEM | 291 | Q96MX6 | |
| DNKGVIYKPATKMET | 336 | O43570 | |
| DPDMIKTVLVKECYS | 86 | P08684 | |
| EAAIKAIMRTQVDPY | 606 | Q3V5L5 | |
| PEEKVSIYKLTGAVM | 346 | P13535 | |
| SDLVAQYVAKNPKLM | 1661 | O43157 | |
| QDVMKLAYADTLPNV | 181 | Q9H255 | |
| DVPQVIKLACMDTYV | 181 | Q8NH05 | |
| KKMVPDFYVDSIADL | 301 | A6NDG6 | |
| RSSEKMVEPQYQELK | 121 | O00625 | |
| DEMPEAAVKSTANKY | 31 | P51858 | |
| AKPNYRIMVEVSLQK | 346 | Q14005 | |
| VPSAKKAIYMDDDVI | 161 | Q68CQ7 | |
| PGDSKEVQVMAERYK | 176 | Q9NX02 | |
| VQEVDLKLKYVMQPD | 4131 | P98164 | |
| KEYGALSNMPVAKEE | 251 | Q07075 | |
| RMKLVTTEPAINEKY | 336 | Q9HAQ2 | |
| QELSKVFPEDMAKYR | 111 | Q9BTT4 | |
| MKPYTSFQELVGEKE | 471 | P23219 | |
| VVAKVCFMYASDPAK | 131 | Q8TDV0 | |
| NEYVAIKLEPMKSRA | 66 | Q9Y6M4 | |
| LKVVKPLDYEAMQSL | 331 | Q02413 | |
| LKSMVQYLKSVDIPE | 111 | Q2TAA2 | |
| EPSEKIMAAVVIQSY | 1331 | Q96JM4 | |
| VYKERFPKATAQMEE | 181 | Q9Y2H9 | |
| DIENAYKKTFLPEMS | 236 | O95299 | |
| EETPKDKQVYMTVAV | 381 | Q5R372 | |
| EFKATYKEMIRIDPQ | 1156 | Q92729 | |
| AAKTLRNYKPNMVET | 1411 | Q92729 | |
| VKAFAPDSIQDSMKY | 2161 | Q6V1P9 | |
| IIVDITKDTFYKQPM | 441 | P04062 | |
| VPLESTKAYNMVDII | 306 | P05166 | |
| YDDPATKMNEETRKL | 151 | P98173 | |
| LKANLKMEAYVPSEE | 2666 | Q8NFC6 | |
| SSDMPIKFDKILYNE | 216 | P0C862 | |
| AVSKAMIPLQAYAKE | 736 | Q9P2D7 | |
| ESMDYDPLVVKLNKD | 806 | Q96A65 | |
| YKRSAVEQAPIDMSK | 201 | O15072 | |
| QTEATNAIAEMKYPK | 211 | Q8NHM5 | |
| DPDMIKTVLVKECYS | 86 | Q9HB55 | |
| IYTDKLKNIMQVAEP | 241 | Q8NEX9 | |
| EIMAKAAEKTPYVVV | 4216 | Q9UFH2 | |
| MEEFAVEYKIINPKA | 1736 | Q8TD57 | |
| YAIEVFKPMADAAVK | 91 | Q9NVM4 | |
| IYAKPANKQEDEVMR | 116 | O15145 | |
| VDVMPVDKRKTYIAS | 461 | Q9H336 | |
| KMFVDLNPDSDKIIY | 311 | P29992 | |
| VYQFKDMPKNIVVID | 286 | Q15723 | |
| EQTYAEMPKAEKNAV | 161 | Q9BY32 | |
| QSVPEDLVVMAEQYK | 591 | Q86TM3 | |
| ERYMKQAIVDKVPSV | 141 | Q9Y678 | |
| MDPKELDKVFNDYTA | 511 | P42892 | |
| KTALPNMDREAKEEY | 226 | P55286 | |
| DKANISEKSVMHPEY | 4636 | Q8NDH2 | |
| DPDMIKTVLVKECYS | 86 | P24462 | |
| DSAIKCEYMLNAIPK | 86 | O95718 | |
| VTTILEDPYVMLKKN | 411 | P42261 | |
| VKEMSYDPQAKLQRL | 461 | Q14147 | |
| YEQMKCLKPEDVAEA | 221 | Q6UWP2 | |
| QMDITKPVQIKDAYS | 136 | P37059 | |
| KPVQIKDAYSKVAAM | 141 | P37059 | |
| VPLEKKINMSYSAEE | 241 | P51170 | |
| RIKSILNAYPSEKEM | 2531 | Q9NZJ4 | |
| TPYEDIEKQDAKISM | 161 | Q9BV19 | |
| KVADIEKASIMYPSN | 41 | O14625 | |
| VRKKEVYMPSSIFQD | 186 | P0C0L4 | |
| VLAEIPDQLVSYMKA | 546 | Q9HCH3 | |
| KVRMIVCVNPKAEDY | 406 | Q02241 | |
| SKDKMAEDEVEVYIP | 296 | P05120 | |
| NPIIYTLRNKDMKEA | 286 | Q8NGZ4 | |
| IPVNYMKELELVTKA | 396 | P06865 | |
| CAAKAQYPIADLVKM | 936 | Q13423 | |
| PELENMTKYVSKLEE | 536 | Q8N807 | |
| DYMLDAKPKEISEIQ | 301 | Q8NBR6 | |
| ILADPLDQMKAEAYK | 181 | Q16799 | |
| TYKAMLLPKSLEQAD | 451 | Q9H7C4 | |
| MQEYAITNDKTKRPV | 1196 | Q9NRR4 | |
| LEAKLSRMSYPVKEQ | 211 | Q8WV83 | |
| SQLPEKVEYVIKCDM | 956 | P51531 | |
| PESNQKMKDSYLILD | 291 | Q8WXG1 | |
| VDVDKPDEKSIMTYV | 261 | Q8NF91 | |
| PDEKSIMTYVAQFLK | 266 | Q8NF91 | |
| VPVMDAQYKIITKTA | 756 | Q8NF91 | |
| VVDPDEKSIMTYVAQ | 266 | Q8WXH0 | |
| NIRPMKKTIAEIVSY | 3936 | Q8WXH0 | |
| LAAKVVQMFYVAEPK | 626 | Q969F9 | |
| IPQKAKEAILEMDSY | 401 | A1L390 | |
| KTAMLQVLAKDCYPE | 26 | Q92730 | |
| FDPESMINGVVKAYK | 446 | Q8IVG5 | |
| SSPKKEVYFMAIIDI | 356 | P78356 | |
| LEAAVLMKKSETYAP | 736 | Q96Q15 | |
| LSPDIMKDAYVQKLV | 121 | Q8NEK8 | |
| EEKFMAANPSKISYE | 1876 | Q14524 | |
| IMYAAVDSVNVDKQP | 1411 | Q15858 | |
| AQLPEKVEYVIKCDM | 986 | P51532 | |
| EILVKYLPSTDKQMD | 301 | Q9NVD3 | |
| AMEKVANSVLFPCKY | 86 | Q8IUQ4 | |
| AMEKVASAVLFPCKY | 126 | O43255 | |
| KKRSYSEPEKMNEVG | 1016 | Q8TF72 | |
| LEKTYGEMAKIVDVP | 271 | Q8TE99 | |
| IPKEEVKEAYMGNVL | 81 | P24752 | |
| EASQIRKDKYMANLP | 681 | Q13017 | |
| VTVMKVEKAPQETYA | 171 | P62191 | |
| DKVSALMQPSQKRYV | 146 | Q68CZ2 | |
| PVIYSLRNKDVKDSM | 326 | Q8NGG2 | |
| VDKNMKYIPTEDVSG | 541 | Q13490 | |
| TIFKVNKDPYVADME | 1881 | Q13023 | |
| TAFEVAEKYLDIPKM | 221 | Q08043 | |
| FKIVYVAPMKALAAE | 531 | Q8N3C0 | |
| MIIVAISPKYKQDVE | 466 | O43734 | |
| SNPDKAKQVELMRDY | 576 | Q86X52 | |
| AEIKQAMLIKYVPAQ | 191 | Q8NHS4 | |
| DYPINLAAIKMQTKV | 1191 | O75122 | |
| AKPKITYVENQTAME | 306 | P13591 | |
| LEKVAMEDYKDNPAF | 206 | Q8IWZ8 | |
| LKIAPESAIKFMAYE | 251 | Q6KCM7 | |
| YVTLKEMPAVLVFKD | 191 | Q96JJ7 | |
| FKIVADKTPYLTMEE | 86 | Q8N1K5 | |
| EIAVPELDGKTAKMY | 96 | Q9Y3C8 | |
| CQIMKDVPSYKEAED | 1801 | Q86UP3 | |
| LAPSQKKLYRDVMQE | 21 | Q3KP31 | |
| SKALKFDPENEYVLM | 406 | Q86TZ1 | |
| APTNIVYKIDDMTAA | 86 | P15927 | |
| SKVIYMARNPKDLVV | 126 | Q9BR01 | |
| TVINDPLYKENAMKL | 431 | P06133 | |
| NKAMYVRVSFDTKPD | 151 | Q9HCF6 | |
| PNEYIKTLADMKVTL | 736 | O94964 | |
| KIIYVARNPKDNMVS | 131 | O75897 | |
| ARIKNLMKEAPTAYS | 171 | Q06203 | |
| MTTDAPKKIVAAKYE | 501 | Q92576 | |
| KEQSNPYMVLDIDKL | 1191 | O75116 | |
| AVKQYISKMIEDSGP | 6 | Q9NRW7 | |
| VPELQSAMKYKVSVR | 636 | P08922 | |
| NTVYSTVEIPKKMEN | 301 | Q9NQ25 | |
| QLMKDKVFSEVSPLY | 266 | Q8TEA7 | |
| EFGAKSKPYLTVDQM | 231 | Q9NQ66 | |
| ALSLVEYKPELQKAM | 606 | O95347 | |
| MADLEVYKNLSPEKV | 1 | Q4KWH8 | |
| VYKNLSPEKVERCMS | 6 | Q4KWH8 | |
| SAELQAYPALVVEKM | 3436 | P78527 | |
| YRTPTAKEVLKDMGQ | 106 | Q9Y584 | |
| KKLQETNYDVMLIDP | 136 | Q6UWM9 | |
| VINDPSYKENIMKLS | 431 | P36537 | |
| KIAPESAIKFMAYEQ | 251 | Q9BV35 | |
| AIPMYKIATKNDVDV | 151 | P36543 | |
| TVINDPSYKENVMKL | 431 | Q9BY64 | |
| RVINDPSYKENVMKL | 431 | P16662 | |
| KTEPLDFNDYKVLMA | 391 | O60315 | |
| YKEAPPDISKAEVTM | 166 | Q13769 | |
| KMYSEIDIKVADPVV | 646 | Q15029 | |
| LKKTENISYEMLFEP | 996 | Q9HAU0 | |
| SSLLPQKQEVYMREK | 146 | Q6ZNG1 | |
| PDKISIMKRISEYAA | 521 | Q86UV5 | |
| MEEEIPKNYSIAQKR | 1736 | Q9Y4A5 | |
| EVLPTKMSYAANLKN | 2096 | O95071 | |
| KSKLEDMFPAYLQEA | 1761 | O14686 | |
| VDAAYMNKVELQAKV | 236 | Q14CN4 | |
| YVEVSKMKINVTEIP | 151 | Q13287 |